Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Harry T. Whelan MD
Professor
Department of Neurology
Division of General

OFFICE ADDRESS:
Children's Corporate Center
999 N 92 St
Milwaukee, WI 53226

EDUCATION:
1971 - 1972 General Motors Institute
1972 - 1975 B.A., University of Wisconsin--Milwaukee
1975 - 1979 M.D., University of Wisconsin--Madison

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1979 - 1981 Intern/Resident, Department of Pediatrics, University of Florida, Gainesville, FL
1981 - 1984 Fellow, Pediatric Neurology, University of Minnesota, Minneapolis, MN
1990 - 1984 NeuroOncology American Cancer Society Clinical Oncology Career Development Award, Vanderbilt University, TN

MILITARY SERVICE:
Diving Medical Officer, NR Navy Experimental Diving Unit, Deep Submergence Unit
Deputy Chief, Bureau of Medicine and Surgery, UNITED STATES NAVY
Captain, United States Navy RET
Senior Research Officer, Future Plans & Strategy, UNITED STATES NAVY
Senior Medical Officer, Readiness Command - Midwest, UNITED STATES NAVY

FACULTY APPOINTMENTS:
07/01/1984 - 09/30/1988 Assistant Professor of Neurology and Pediatrics, Vanderbilt University, Nashville, TN
10/01/1988 - 1996 Associate Professor of Neurology and Pediatrics, The Medical College of Wisconsin, Milwaukee, WI
05/01/1992 - 1997 Chief of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI
07/01/1996 - Present Professor of Neurology, Bleser Endowed Professor, The Medical College of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Neurology with Special Qualification in Child Neurology (American Board of Psychiatry and Neurology)
1986
None
Board Certified in Undersea & Hyperbaric Medicine (American Board of Preventive Medicine)
2009
None
 
Licensure
Number Issue DateExpiration
State of Wisconsin
28456
None
State of Michigan
4301063981
None
 

AWARDS AND HONORS:
1973 B.A. with Honors, cum laude (University of Wisconsin-Milwaukee)
1974 Travel in USSR; University Soviet Seminar 1974
06/1976 - 09/1976 NIMH Research Fellowship
1979 NIH Clinical Research Elective
1987 - 1990 American Cancer Society--Clinical Oncology Career Development Award
09/1994 United States Navy--Officer Training School First in Class Award, Pensacola Naval Air Station
05/1995 United States Navy--Diving Casualties School First in Class Award, Naval Diving & Salvage Training Ctr
10/21/1995 NAVY ACHIEVEMENT MEDAL, Research
02/01/1996 United States Navy--Direct Presidential Commission as Lieutenant Commander, Promotion to Commander
04/1996 Diving Medical Officer, Naval Diving & Salvage Training Ctr
07/25/1997 NAVY & MARINE CORPS COMMENDATION MEDAL, Professional School Liaison Officer
10/1997 Naval Special Warfare Group TWO
04/2000 Inducted into NASA-Space Technology Hall of Fame
2001 Discover Magazine Award for Technological Innovation
2001 Institute for Space and Nuclear Power Studies Outstanding Paper Award, at the Space Technology & Applications International Forum, "NASA Light Emitting Diode Medical Applications from Deep Space to Deep Sea"
06/01/2002 United States Navy--Promotion to Captain
07/2004 Distinguished Research Professorship, Nat'l Defense University
2008 - Present Bleser Endowed Chair in Neurology, Bleser Foundation
2009 - 2010 Elected to: "Best Doctors in America"
2013 Top-Rated Doctor , M Magazine
2014 Legion of Merit Award, United States Marine Corps
2014 Top-Rated Doctor , M Magazine
2014 - Present Legion of Merit, United States Armed Forces
2015 Top-Rated Doctor 2015, M Magainze

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
Child Neurology Society
American Academy of Neurology
Pediatric Oncology Group Neuroscience Committee
UDT-SEAL Association (Associate Member-DMO)
Naval Submarine League--Life Member
United States Naval Institute
Association of Medical Corps Officers of the Navy - founding member (plank owner)
Undersea & Hyperbaric Medical Society

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
Journal Medical Gas Research
Frontiers in Neurology
Photodermatology, Photoimmunology & Photomedicine
Journal Review
Experimental Neurology
Children's Cancer Study Group
Developmental Pharmacology and Therapeutics
Pediatric Neurology
Archives of Neurology
Southern Medical Journal
Clinical Pediatrics
Pediatric Dermatology
Radiation Research
Journal of Photomedicine and Laser Surgery
Neurology
World Neurology Journal

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2002 Endowed Professorship, Bleser Foundation
2004 - Present Honorary Professorship, University of Illinois, Chicago
2004 - Present Honorary Professorship, University of Wisconsin, Milwaukee

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
08/01/2015 - Present International Board Member-CAPT U.S. Navy (ret), Undersea Medicine Inc. (IBUM)
Medical Devices, Inc, Chief Scientific officer, Board of Directors
International Affairs Committee of the Child Neurology Society Neuroscience Committee, Pediatric Oncology Group
Distinguished Research Professor, Institute for Technology and National Security Policy, National Defense University
Neuroscience Committee, Children's Oncology Group.
Study Committee of CCG-105N - "Neuropsychologic Function in Four-Year Survival of ALL".
Chairman of Central Nervous System Germ Cell Tumor Study, Pediatric Oncology Group. "Lymphoblastic Leukemia and Its Therapy"
Study Committee of CCG-923 - "Good Prognosis Medulloblastoma: A Study of Reduced Neuraxis Radiation in Newly Diagnosed Children"
Craniopharyngioma Protocol, Ped Oncology Group. Program Director. Innate Immunity for Biodefense. Center for Technology and National Security Policy
National Defense University, Washington D.C.
Associated Military Surgeons of the United States (AMSUS)
DARPA, NASA, National Defense University Progress Report
Research Grant Reviewer for Office of Naval Research
Study Committee of CCG-105NP - "A Longitudinal Study of the Neuropsychological Effects of Acute Committee.

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Bleser Foundation - Endowed Professorship
Dates:
01/01/2004 - Present
Direct Funds:
$1,000,000 (as eternal endowed trust for Dr. Whelan to provide ~$70-100,000/yr. (indexed for inflation) INCREASED TO $2,000,000 in 2008. ENDOWED CHAIR in 2008)
 
Title:
Hyperbaric Oxygen Therapy for Stroke
Source:
CTSI
Role:
PI
Dates:
2007 - 2013
 
Title:
Electrophysiological Effects of Underwater Voltage Gradient Defense System
Source:
US Navy Experimental Diving Unit
Dates:
2007 - 2014
 
Title:
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study
Source:
CTSI
Role:
PI
Dates:
2007 - 2013
 
Title:
Long-Wavelength, low-intensity photon therapy (LLPT) for traumatic brain injuries
Source:
DARPA Contract 56482-LS-DRP
Role:
P.I.
Dates:
2009 - 2014
Direct Funds:
$2,150,000 ($150,000 for 1st year, $1,000,000 each for 2nd and 3rd years)
 
Title:
Mechanisms of antimicrobial effect of blue light on MRSA
Source:
NIH CTSI
Dates:
04/01/2012 - 03/13/2014
 
Title:
PDT for Brain Tumor Dispersal
Source:
Pinnacle Biologics, Inc
Role:
PI
Dates:
2012 - 2017
 
Title:
Cerebral oxygen saturation in children with epilepsy: A pilot study
Source:
Covidien
Role:
PI
Dates:
2012 - 2017
 
Title:
Photodynamic Therapy for Childhood Brain Tumors
Source:
NIH/CTSI
Role:
PI
Dates:
2012 - 2014
 
Title:
Hyperbaric Oxygen Therapy (HBO2T for Migraine Headache
Source:
Froedtert Hospital Foundation
Role:
PI
Dates:
2014 - 2015
Direct Funds:
$20,000
 
Title:
Neurology Research Program in Brain Blood Flow
Source:
Bleser Family Foundation
Role:
PI
PI:
Harry Whelan
Dates:
01/01/2019 - 12/31/2022
Direct Funds:
$1,000,000 (The overall purpose of this project is to capitalize on our expertise in photobiology and clinical neurology in order to utilize the power of near-infrared light in the diagnosis and treatment of children with neurologic problems.)
 
Title:
Neurobiological and physiological measurements from free swimming marine mammals
Source:
Office of Naval Research
Role:
PI
Dates:
04/01/2019 - 03/31/2022
Direct Funds:
$100,000 (Objective: Investigation and characterization of light propagation through marine mammal tissue)
 
Non-Peer Review
Title:
Chad Baumann Research Foundation Endowment
Source:
Endowed Research Fund
Dates:
01/01/2004 - Present
Direct Funds:
$1,000,000 (as eternal endowed trust for Dr. Whelan to provide ~$7-10,000/yr. (indexed for inflation))
 
Prior
Peer Review
Title:
Studies on the Role of Trophic Factors in Brain Tumor Biology
Source:
Vanderbilt Children's Hospital Research Fund
Role:
P.I.
Dates:
1984 - 1985
Direct Funds:
$35,000
 
Title:
Studies of CNS Regeneration in an Amphibian Model System
Source:
Vanderbilt University Research Council
Role:
P.I.
Dates:
1984 - 1985
Direct Funds:
$5,000
 
Title:
Evaluation of Substances Found in Fetal Lung for Neurotropic and Neurotrophic Activity
Source:
N.I.H. (BRSG)
Role:
P.I.
Dates:
1986 - 1987
Direct Funds:
$15,000
 
Title:
Studies on the Role of Trophic Factors in Brain Tumor Biology
Source:
American Cancer Society Clinical Oncology Career Development Award
Role:
P.I.
Dates:
1987 - 1990
Direct Funds:
$90,000
 
Title:
Photodynamic Therapy for Brain Tumors
Source:
Midwest Athletes Against Childhood Cancer Fund
Role:
P.I.
Dates:
1988 - 1995
Direct Funds:
$90,000
 
Title:
Studies on the Role of Trophic Factors in Brain Tumor Biology
Source:
Cancer Center Seed Grant
Role:
P.I.
Dates:
1988 - 1989
Direct Funds:
$7,500
 
Title:
MR Imaging with MR Spectroscopy in Pediatric Brain Tumors
Source:
MCW - Clinical Research Center
Role:
P.I.
Dates:
1990 - 1991
Direct Funds:
$7,500
 
Title:
MR Imaging with MR Spectroscopy in Pediatric Brain Tumors
Source:
MCW - Clinical Research Center
Role:
P.I.
Dates:
1990 - 1991
Direct Funds:
$7,500
 
Title:
The Role of Growth Factors in Pediatric Brain Tumor Biology
Source:
The Cancer Research Foundation of America
Role:
P.I.
Dates:
1991 - 1992
Direct Funds:
$30,000
 
Title:
Pre-Clinical Evaluation of Feasibility of Photodynamic Therapy (PDT) in Pediatric and Adult Brain Tumors
Source:
American Cancer Society
Role:
P.I.
Dates:
1991 - 1993
Direct Funds:
$84,000
 
Title:
Synthesis of a Toxic Growth Factor Conjugate for Brain Tumors
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1991 - 1992
Direct Funds:
$30,000
 
Title:
Clinical Trials and Laboratory Studies of Photodynamic Therapy/Gallium Therapy for Brain Tumors
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1992 - 1997
Direct Funds:
$250,000
 
Title:
Comparison of Toxic Growth Factor Conjugates with Gallium for Brain Tumor Therapy
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1992 - 1993
Direct Funds:
$35,360
 
Title:
Gallium Nitrate for Brain Tumors
Source:
MCW - Clinical Research Center
Role:
P.I.
Dates:
1993 - 1998
Direct Funds:
$10,000
 
Title:
Photodynamic Therapy for Brain Tumors
Source:
MCW - Clinical Research Center
Role:
P.I.
Dates:
1993 - 1998
Direct Funds:
$10,000
 
Title:
Laser purchase for Human Photodynamic Therapy Protocol
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1994
Direct Funds:
$75,000
 
Title:
Light Emitting Diode for Photodynamic Therapy
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1995 - 1999
Direct Funds:
$480,000 ($40,000 1st year, $189,000 2nd year, $251,000 3rd year)
 
Title:
NASA/CHW Light-Emitting Diode/Hyperbaric Medical Program
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
1998 - 2001
Direct Funds:
$180,000
 
Title:
Light-Emitting Diodes and Hyperbaric Oxygen for Wound Healing Phase-2
Source:
Children's Hospital Foundation
Role:
P.I.
Dates:
2000 - 2002
Direct Funds:
$251,000
 
Title:
NASA Light-Emitting Diodes as
Source:
NASA/Quantum Devices
Role:
P.I.
Dates:
2001 - 2002
Direct Funds:
$314,500 ($70,000 1st year, $244,5000 remaining years)
 
Title:
LED Treatment, Healing, Post Retinal Laser Injury
Source:
DARPA
Role:
P.I.
Dates:
2001 - 2006
Direct Funds:
$983,900 ($383,900 for 1st year, rest thereafter)
 
Title:
LED Treatment, Healing, Post Corneal Laser Injury
Source:
DARPA
Role:
P.I.
Dates:
2002 - 2005
Direct Funds:
$367,524
 
Title:
Distinguished Research Professorship Appointment, National Defense University
Source:
Office of the Secretary of Defense,Center for Technology and National Security Policy,National Defense University
Role:
P.I.
Dates:
2004 - 2006
Direct Funds:
$250,000
 
Title:
LED Treatment, Healing, Post Corneal Laser Injury
Source:
DARPA
Role:
P.I.
Dates:
2004 - 2006
Direct Funds:
$8,749,997
 
Title:
Light Emitting Diode Therapy for Oral Mucositis
Source:
NASA Contract # NNM 05AB48C
Role:
P.I.
Dates:
2005 - 2009
Direct Funds:
$133,200
 
Title:
NIR-LED Treatment for Parkinson's Disease
Source:
NIH Grant 1R21AT003002-01A1
Role:
P.I.
Dates:
2006 - 2009
Direct Funds:
$389,331
 
Title:
Electrophysiological Effects of Underwater Voltage Gradient Defense System
Source:
NIH Grant 1R21AT003002-01A1
Role:
P.I.
Dates:
2007 - 2010
Direct Funds:
$100,000
 
Title:
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema-A Pilot Study
Source:
Clinical and Translational Science Institute
Role:
P.I.
Dates:
2007 - 2010
Direct Funds:
$100,000
 
Title:
Near Infrared Light Therapy
Source:
Hanger Orthopedics
Role:
P.I.
Dates:
2010 - 2012
Direct Funds:
$100,000
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Chemotherapy of Childhood Brain Tumors. Presented at the Medical College of Wisconsin, Milwaukee, Wisconsin, 09/05/1986
Faculty CME-Course, Pediatric Neurology, Milwaukee, Wisconsin, 08/19/1989
Advances in Therapy of Childhood Brain Tumors. Presented at the Milwaukee Neuro-Psychiatric Society. University Club, Milwaukee, Wisconsin, 11/15/1989
Effects of Gallium Nitrate on Human Brain Tumor Cells. Presented at the Midwest Neuro-Oncology Conference. University of Wisconsin, Madison, Wisconsin, 08/02/1990
Tumors of the Central Nervous System. Department of Neurosurgery CME Symposium. Froedtert Memorial Lutheran Hospital, 09/25/1992
Medical College of Wisconsin CME course in Hyperbaric Medicine. Central Nervous System Oxygen Toxicity Oxygen Toxicity Suppression, 09/08/1997
Children's Hospital Grand Rounds. Photobiomodulation of Mitochondrial Energy Metabolism, 12/2007
Harry Whelan MD, Edit Olasz MD, Brendan Quirk PhD, Photodynamic Therapy for Benign Dermal Neurofibromas, Children’s Research Institute Research Conference, Children's Hospital of WI, 01/29/2016
Harry Whelan, Edit Olasz, Brendan Quirk, Donald Basel, Photodynamic Therapy for Benign Dermal Neurofibromas, Children's Hospital of Wisconsin, Children's Research Institute Research Conference, Milwaukee, WI, 01/19/2018
Harry Whelan, Edit Olasz, Teju Deshmukh, Jack Vo, Donald Basel, Brendan Quirk, Photodynamic Therapy for Benign Neurofibromas, Children's Research Institute Conference, Children's Hospital of Wisconsin, 01/19/2018
Harry Whelan, Brendan Quirk, Wei-Liang Chen, Near-Infrared Spectroscopy for Childhood Epilepsy, Neurology Grand Rounds, Medical College of Wisconsin, 02/09/2018
 
Regional
Agenesis of the Corpus Callosum (Neurologic Causes of Failure to Thrive). Visiting Professor, Pediatric Grand Rounds. University of Minnesota, 11/21/1984
Meningeal Gliomatosis. Presented at the Children's Cancer Study Group Meeting. Chicago, Illinois, 10/28/1985
Meningeal Gliomatosis. Presented at the Children's Cancer Study Group Meeting, Chicago, Illinois, 10/28/1985
The Role of Growth Factors in the Biology of a Brain Tumor Cell Line. Presented at the American Academy of Neurology Meeting, Chicago, Illinois, 04/16/1989
Growth Factors in Brain Tumors. Photodynamic Therapy for Childhood Brain Tumors. Visiting Professor, Neurology Grand Rounds. University of Minnesota, 02/05/1992 - 02/06/1992
Wisconsin Center for Space Automation & Robotics-Madison/NASA. Light Emitting Diode for Photodynamic Therapy, 12/01/1994
Great Lakes Naval Hospital. Neurologic Aspects of Undersea Medicine, 02/16/1995
Wisconsin Boiler Inspectors Association (WBIA) The Uses and Indications of Hyperbaric Medicine CME, 04/2009
Hemodynamic Response Associated with Interictal and Ictal Epileptiform Discharges Using Simultaneous Video Electroencephalography (vEEG) /Near Infrared Spectroscopy (NIRS), Wisconsin Neurologic Society, 10/2013
Photodynamic Therapy for Benign Dermal Neurofibromas, Neurofibromatosis Therapeutic Acceleration Program at Johns Hopkins, Chicago, IL, 08/01/2016
 
National
Primary Diffuse Meningeal Gliomatosis in Children. Presented at the Child Neurology Society Meeting, Phoenix, Arizona, 10/11/1984
Neurotrophic Effects of Adult Amphibian Explant Conditioned Medium. Presented at the Society for Neuroscience Meeting, Anaheim, California, 10/12/1984
The Vanderbilt Experience with Primitive Neuroectodermal Tumors and Anaplastic Astrocytomas. Presented at the Children's Cancer Study Group Meeting, Seattle, Washington, 04/25/1985
The Vanderbilt Experience with Primitive Neuroectodermal Tumors and Anaplastic Astrocytomas. Presented at the Children's Cancer Study Group Meeting, Seattle, Washington, 04/25/1985
Recent Advances in the Treatment of Pediatric Brain Tumors Physicians Radio Network, Stanford, Connecticut, 10/03/1985
In Vitro Studies of Fetal and Adult CNS Regeneration. Presented at the Child Neurology Society Meeting, Memphis, Tennessee, 10/10/1985
Nuclear Magnetic Resonance Brain Tumor Imaging Using an Adult Canine Glioma Model. Presented at the American Academy of Neurology Meeting, New Orleans, Louisiana, 04/29/1986
Recent Advances in Chemotherapy for Childhood Brain Tumors. Cable News Network, 05/29/1986 - 05/30/1986
Central Nervous System Germ Cell Tumors. Presented at the Children's Cancer Study Group Meeting, Seattle, Washington, 03/1987
The Role of Growth Factors in the Biology of a Brain Tumor Cell Line. Presented at the American Academy of Neurology Meeting, New York, New York, 04/09/1987
Neurologic Complications of Cancer Therapy. Presented at the Tenth Annual Symposium Contemporary Clinical Neurology. Hilton Head, South Carolina, 07/20/1987 - 07/24/1987
Management of Childhood Brain Tumors. Presented at the Tenth Annual Symposium Contemporary Clinical Neurology. Hilton Head, South Carolina, 07/20/1987 - 07/24/1987
Comparison of X-Ray CT and Magnetic Resonance Brain Tumor Imaging Using an Adult Canine Glioma Model. Presented at the Child Neurology Society Meeting, San Diego, California, 10/22/1987
Faculty - National Neurology Board Review Course. Pediatric Neurology, 02/07/1988
Faculty - National Neurology Board Review Course. Phacomatoses, 02/08/1988
Faculty - National Neurology Board Review Course. Neuromuscular Disorders, 02/08/1988
Recent Advances in Therapy of Childhood Brain Tumors. Presented at the University of Alabama in Huntsville, Huntsville, Alabama, 06/03/1988
Primary CNS Germ Cell Tumors in Children. Presented at the Pediatric Oncology Group Meeting, St. Louis, Missouri, 10/16/1988
Primary Central Nervous System Germ Cell Tumors in Children. Presented at the Pediatric Oncology Group Meeting. Sand Key Island, Florida, 04/15/1989
The Use of MR-Imaging with MR-Spectroscopy in the Study of Medulloblastoma. Presented at the Child Neurology Society Meeting, San Antonio, Texas, 10/13/1989
Medulloblastoma Secretes Platelet-Derived Growth Factor. Presented at the American Academy of Neurology Meeting, Miami, Florida, 05/02/1990
Effects of Gallium on Human Brain Tumor Cells In Vitro. Presented at the Child Neurology Society Meeting, Atlanta, Georgia, 10/18/1990
Faculty Symposium on Frontiers in Cancer Biology at MCW Cancer Center, 04/06/1991
Increasing Cyclic AMP with Forskolin Decreases Growth Factor Dependent Proliferation of Brain Tumor Cells. Presented at the American Academy of Neurology Meeting, Boston, Massachusetts, 04/23/1991
Photodynamic Therapy for Childhood Brain Tumors. Presented to the American Cancer Society, 09/27/1991
Interactions of Merocyanine-540 with Human Brain Tumor Cells: Preferential Binding In Vivo and Dye-Sensitized Photoinactivation In Vitro. Presented at the Child Neurology Society Meeting, Portland, Oregon, 10/04/1991
Intracellular Growth Factor Metabolism in Proliferation of a Brain Tumor Cell Line. Presented at the American Academy of Neurology Meeting, San Diego, California, 05/06/1992
The Role of Photodynamic Therapy in Posterior Fossa Brain Tumors: A Pre-Clinical Study in a Canine Glioma Model. Presented at the Child Neurology Society Meeting, New Orleans, Louisiana, 10/23/1992
Selective uptake of 111In-Photofrin in brain tumors. Presented at the Child Neurology Society Meeting, Orlando, Florida, 10/14/1993
Gallium Nitrate for Malignant Solid Tumors of Childhood. Pediatric Oncology Group, Ft. Lauderdale, FL, 04/1994
Selective Incorporation of 111In-Labeled PHOTOFRIN by Glioma Tissue in vivo. Presented at the Pediatric Neuro-Oncology Sixth International Symposium, Houston, Texas, 05/1994
Gallium Nitrate Delays the Progression of Microscopic Disease in a Human Medulloblastoma Model. Presented at the Pediatric Neuro-Oncology Sixth International Symposium, Houston, Texas, 05/1994
American Cancer Society - Wisconsin Chapter & EXCALIBUR CLUB. Photodynamic Therapy for Child Brain Tumors, 07/1994 - 08/1994
A simple and Rapid Method for Determination of Felbamate. Presented at the American Association of Clinical Chemistry, Washington, DC, 07/1994
President's Council for Children's Hospital. Photodynamic Therapy for Childhood Brain Tumors, 02/15/1995
Use of cytochrome P450 inhibitors to alter seizures caused by CNS-oxygen toxicity. Presented at the Undersea & Hyperbaric Medical Society, Palm Beach, Florida, 06/1995
Association of Military Surgeons of the United States. Neurologic Aspects of Undersea Medicine, 11/01/1995
Neuronal culture model of CNS-oxygen toxicity. Presented at the Society for Neuroscience, San Diego, California, 11/1995
Space Technology Applications International Forum. Light Emitting Diodes for Brain Tumor Photodynamic Therapy, 11/11/1996
International Society on Oxygen Transport to Tissue. Hyperbaric Oxygen: Some Unanswered Questions Despite Clinical Usefulness, 08/22/1997
Hyperbaric oxygen enhancement of radiation therapy via central nervous system oxygen toxicity suppression. Presented at the Society for Neuroscience, New Orleans, Louisiana, 10/29/1997
Physiological stress measurements in US Navy SEALS. Special Operations Medical Conference, Tampa, Florida, 12/05/1997 - 12/13/1997
Space Technology & Applications International Forum. Benzoporphyrin Derivative and Light-emitting Diode for Use in Photodynamic Therapy: Applications of Space Light-emitting Diode Technology, 01/1998
Space Technology Applications International Forum. Medical Applications of Space Light-Emitting Diode Technology: Space Station & Beyond, 01/1999
NASA Program Meeting. NASA LED-Medical Program, 05/1999
NASA Technology - East Division Space. Space Applications of NASA LED-Medical Program, 11/1999
Medical Aspects of Special Warfare Automated Mission Planning System. Special Operations Medical Conference, Tampa, Florida, 12/1999
Space Technology & Applications International Forum. NASA Light-Emitting Diode Medical Program - Progress in Space - Flight and Terrestrial Applications, 01/2000
Space Technology & Applications International Forum. NASA Light-Emitting Diode Medical Program - Progress in Space - Flight and Terrestrial Applications, 01/2000
Space Technology & Applications International Forum. NASA-LED Medical Applications - Deep Space to Deep Sea, 02/2001
Space Technology & Applications International Forum. NASA-LED Medical Applications - Deep Space to Deep Sea, 02/2001
NASA-LED Technology: Applications for Battlefield Self-Care. Defense Advanced Research Projects Agency - Self-Care Workshop, 04/2001
Light-Emitting Diode (LED) Treatment Healing Post-Retinal Laser Injury. Defense Advanced Research Projects Agency - Self-Care Workshop, 05/2001
NASA-LED Near-IR Technology for Biostimulation. NASA/DARPA Photobiology Workshop, 06/2001
Society for Neuroscience Annual Meeting. San Diego, 11/01/2001
SOMA - Special Operations Medical Conference. Tampa, FL, 12/2001
Photonics West. San Jose CA, 01/2002
Effects of near-infrared light on methanol-induced mitochondrial dysfunction in the retina. Lasers on the Modern Battlefield Conference. Brooks Air Force Base, TX, 02/2002
NIH Presentation to NCMRR Advisory Board. Washington DC, 05/01/2002 - 05/02/2002
Association for Research in Vision and Ophthalmology Annual Meeting. Ft. Lauderdale, FL, 05/04/2002 - 05/10/2002
DARPA DSO Technology 2002 Symposium. DARPA Photobiomodulation Research. Anaheim, CA, 07/29/2002 - 08/02/2002
DARPA DSO. Persistence in Combat (PIC) DARPA Photobiomodulation Research, St. Petersburg, FL, 09/05/2002 - 09/08/2002
SOMA - Special Operations Medical Conference. DARPA Photobiomodulation Research. Tampa, FL, 12/2002
Defense Advanced Research Projects Agency 2002. 22nd Systems and Technology Symposium, 2002
Lasers on the Modern Battlefield Conference. Photobiomodulation for Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED) Brooks AFB. San Antonio, TX, 02/2003
Lasers on the Modern Battlefield Conference. Photobiomodulation for Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED). Brooks AFB, San Antonio, TX, 02/2003
DARPA Photobiomodulation Research. San Diego, CA, 03/2003
DARPA Photobiomodulation Research. San Diego, CA, 03/2003
Third Congress of the North American Association for Laser Therapy (NAALT) Uniformed Services University of the Health Sciences. DARPA Photobiomodulation Research. Bethesda, MD, 04/2003
US Navy Bureau of Medicine and Surgery (BUMED) DARPA Photobiomodulation Research. Washington, DC, 04/2003
Commander, Naval Medical Center Portsmouth. DARPA Photobiomodulation Research, Portsmouth, VA, 05/2003
Naval Special Warfare Development Group. DARPA Photobiomodulation Research. Norfolk, VA, 05/2003
Naval Special Warfare Group TWO. DARPA Photobiomodulation Research, Norfolk, VA, 05/2003
Naval Medical Research Center. DARPA Photobiomodulation Research. Silver Spring, MD, 05/2003
ElectroMed 2003. Third International Symposium, DARPA Photobiomodulation Research, San Antonio Texas, 06/2003
Persistence in Combat/ReGenesis Review Meeting. DARPA Photobiomodulation Research, Arlington, VA, 06/2003
BIO 2003 Annual Convention. DARPA Photobiomodulation Research, Arlington VA, 06/2003
Advanced Technology Application For Combat Casualty Care (ATACCC), DARPA Photobiomodulation Research, St. Petersburg, FL, 08/2003
SOMA - Special Operations Medical Conference. DARPA Persistence in Combat program, Tampa, FL, 12/2003
SOMA - Special Operations Medical Conference. DARPA Persistence in Combat program, Tampa, FL, 12/2003
Lasers in the Modern Battlefield XXV Annual Conference. Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED) San Antonio, TX, 02/2004
Lasers in the Modern Battlefield XXV Annual Conference. Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED). San Antonio, TX, 02/2004
Beyond Genome. Photobiology in Biological Systems: Low-Level Energy Therapy for Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED), San Fransisco, 06/2004
Beyond Genome. Photobiology in Biological Systems: Low-Level Energy Therapy for Treatment for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED). San Francisco, CA, 06/2004
NAVY Experimental Diving Unit. DARPA and National Defense University Research, Panama City, FL, 08/2004
DARPA/DSO. Soldier Self Care Principal Investigator Meeting, Arlington, VA, 08/2004
Associated Military Surgeons of the United States (AMSUS). DARPA, NASA, National Defense University Progress Report. Denver, CO, 11/2004
Innate Immunity for Biodefense. Center for Technology and National Security Policy, National Defense University Senior Seminar Series. Program Director., Washington, DC, 11/2004
Office of the Secretary of Defense. Presentation to OSD-Chemical/Biological Defense, Innate Immunity for Biodefense, Washington DC, 01/2005
FDA. Innate Immunity for Biodefence, Washington DC, 01/2005
Lasers in the Modern Battlefield XXVIth Annual Conference. LED Countermeasures for laser Eye Injury. Brooks AFB, San Antonio, TX, 02/2005
Lasers in the Modern Battlefield. LED Countermeasures for laser Eye Injury. San Antonio, TX, 02/2005
Lasers in the Modern Battlefield. DARPA Program Update: Near Infrared Treatment for Laser Eye Injury. San Antonio, TX, 02/2006
Lasers in the Modern Battlefield. DARPA Program Update: Near Infrared Treatment for Laser Eye Injury. San Antonio, TX, 02/2006
Lasers in the Modern Battlefield. Near Infrared Treatment for Laser Eye Injuries. San Antonio, TX, 02/2007
American Heart Association. International Pediatric Stroke Study. History of TPA in Childhood Stroke, 02/2007
Lasers in the Modern Battlefield. Near Infrared Treatment for Laser Eye Injuries, San Antonio, TX, 02/2007
Undersea & Hyperbaric Medical Society Annual Scientific Meeting. Lightweight, Faster Decompression and Portable Alternative to U.S. Navy Mixed Gas Diving, 06/2007
Undersea & Hyperbaric Medical Society Annual Scientific Meeting. Hyperbaric Oxygen fir Acute Ischemic Stroke: Need for a Better Study, 06/2007
Child Neurology Society 36th Annual Meeting. Photodynamic Therapy for Dermal NF1 Tumors, 10/2007
MITRE - CIA. Intelligence Community Interactions with Scientist Consultants in Counter-Terrorism, 01/2008
Lasers in the Modern Battlefield. Near-infrared light (NIR-LED) treatment of laser-induced retinal injury, 02/2008
Lasers in the Modern Battlefield. Near-infrared light (NIR-LED) treatment of laser-induced retinal injury. San Antonio, TX, 02/2008
NASA Spinoff Day on the Hill. Testifying to Congress. Medical Applications of Quantum Devices' Light-Emitting Diodes (LED's) Washington DC, 04/2008
The North American Association for Laser Therapy (NAALT) Keynote Speaker. Introduction to laser and laser therapy, 06/2008
UHMS. Advantages of Trimix Rebreathers over Conventional "Bounce" Diving. Salt Lake City, UT, 06/2008
The North American Association for Laser Therapy (NAALT) Keynote Speaker. Introduction to laser and laser therapy. Palm Beach, FL, 06/2008
Undersea & Hyperbaric Medical Society. New Method for Saturation Diving Lighter, Faster Decompression and Portable Alternatives to U.S. Navy Mixed Gas Diving, 06/2008
Hyperbaric Medicine Symposium - Neurologic Aspects of Hyperbaric Medicine. Corse Co-director. Sponsored by United States Congress, NASA, and the Canadian Ministry Defence. Synergy of Hyperbaric Oxygen with Near Infrared (NIR) Light for Treatment of Traumatic Brain Injury, 10/2008
Naval Diving Salvage and Training Center, US Navy. New Developments in Submarine Rescue - Diving Medical Perspective. Hyperbaric Oxygen Therapy for Acute Stroke. Near Infrared (NIR) Light Therapy for Neurologic Aspects of Undersea Medicine, 10/2008
Hyperbaric Medicine Symposium - Neurologic Aspects of Hyperbaric Medicine. Corse Co-director. Sponsored by United States Congress, NASA, and the Canadian Ministry Defence. Synergy of Hyperbaric Oxygen with Near Infrared (NIR) Light for Treatment of Traumatic Brain Injury, 10/2008
Naval Diving Salvage and Training Center, US Navy. New Developments in Submarine Rescue - Diving Medical Perspective Hyperbaric Oxygen Therapy for Acute Stroke Near Infrared (NIR) Light Therapy for Neurologic Aspects of Undersea Medicine, 10/2008
Child Neurology Society 37th Annual Meeting. Harnessing the Cell's Own Ability to Repair and Prevent Neurodegenerative Disease, 11/2008
Child Neurology Society 37th Annual Meeting. Harnessing the Cell's Own Ability to Repair and Prevent Neurodegenerative Disease, 11/2008
Mechanisms for Low Light Therapy IV SPIE. Near-infrared Light as a Possible Treatment Option for Parkinson's disease and Laser Eye Injury, 01/2009
GE Translational Institute Medical Symposium. Photobiomodulation as Applied to Cardiac Disease, 01/2009
Mechanisms for Low Light Therapy. Near-infrared Light as a Possible Treatment Option for Parkinson's disease and Laser Eye Injury, 01/2009
The American Society for Laser Medicine and Surgery (ASLMS) Near-Infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury, 04/2009
The American Society for Laser Medicine and Surgery (ASLMS). Near-Infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury, 04/2009
Undersea & Hyperbaric Medical Society. Neurologic Aspects of Hyperbaric Medicine, 06/2009
The North American Association for Laser Therapy (NAALT) Near-Infrared Light as a Possible Treatment Option for Parkinson's disease and Laser Eye Injury, 06/2009
Undersea & Hyperbaric Medical Society. Neurologic Aspects of Hyperbaric Medicine, 06/2009
The North American Association for Laser Therapy (NAALT) Near-Infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury, 06/2009
The Society for Laparoendoscopic Surgeons (SLS) Photobiomodulation of Mitochondrial Mechanisms in Neurodegenerative Disease, 09/2009
Society of Laparoendoscopic Surgeons. Controlling Molecules With Light, 09/2009
Society for Neuroscience. Near-infrared light treatment in an in vitro model of traumatic brain injury, 10/2009
Society for Neuroscience. Near-infrared Photobiomodulation is Neuroprotective in a Transgenic Mouse Model of Parkinson's Disease, 10/2009
Conscious Life Expo. Near-infrared photobiomodulation is neuroprotective in a transgenic mouse model of Parkinson's disease, 02/2010
ASLMS. Near-infrared light treatment in an in vitro model of traumatic brain injury, 04/2010
ARVO. Treating and Preventing the Devastating Effects of Age-Related Macular Degeneration (AMD), 04/2010
Undersea & Hyperbaric Medical Society Mid-West Chapter Comprehensive Forum. DSRV. Infrared Light and Wound Care, 10/2010
American Academy of Neurology (AAN) Long-Wavelength, Low-Intensity Photon Therapy (LLPT) for Traumatic Brain Injury, 04/2011
Ayn Rand Center. Presentation for Strategies Enhancing Medical Innovation, 08/2011
The North American Association for Laser Therapy (NAALT) Effects of Near-Infrared Light on the Enzyme Kinetics of Cytochrome Oxidase, 09/2011
The North American Association for Laser Therapy (NAALT) Effects of Near-Infrared Light on the Enzyme Kinetics of Cytochrome Oxidase, 09/2011
The Use of Hyperbaric Oxygen for Treating Delayed Radiation Injuries in Gynecologic Malignancies: A Review of Literature and Report of Radiation Injury Incidence, Undersea & Hyperbaric Medical Society, Phoenix, 06/2012 - Present
Ketogenic Diet to Decrease Central Nervous System Oxygen Toxicity Symptoms in Divers, Undersea & Hyperbaric Medical Society (UHMS), 06/2013
Photodynamic Therapy for Brain Tumors, Society for Neuro-Oncology (SNO), 11/2013
Photodynamic Therapy (PDT) of Brain Tumors & Hemodynamic response associating with both interictal and itcal epileptiform activities using simultaneous video Electro-encephalography (EEG)/Near Infrared spectroscopy (NIRS), American Academy of Neurology (AAN), 04/2014
Hyperbaric oxygen treatment for post-radiation central nervous system injury: A retrospective case series, Undersea & Hyperbaric Medical Society (UHMS), 06/2014
Basic principle of Near Infrared Spectroscopy and Application in monitoring cerebral oxygenation, Undersea & Hyperbaric Medical Society (UHMS), 06/2015
In Water Recompression for Undersea Diving, Undersea & Hyperbaric Medical Society Annual Scientific Meeting, Las Vegas, NV, 06/08/2016 - 06/11/2016
Ketogenic Diet for Prevention of Central Nervous System Oxygen Toxicity in Closed-Circuit Oxygen Rebreather Diving, Conference on Nutritional Ketosis and Metabolic Therapeutics: Epigenix Foundation, Tampa, FL, 02/02/2017 - 02/04/2017
Harry Whelan, Ketosis as a Neuroprotective Mechanism to CNS Toxicity in Divers Exposed to High Partial Pressure of Oxygen (PO2), Undersea & Hyperbaric Medical Society Annual Scientific Meeting, Orlando, FL, 06/28/2018
Neurobiological and Physiological Measurements From Free Swimming Marine Mammals, Undersea & Hyperbaric Medical Society Annual Scientific Meeting, San Juan, Puerto Rico, 06/27/2019 - 06/29/2019
 
International
Transforming Growth Factor Beta in Brain Tumor Biology. Presented at the Society for Neuroscience Meeting, Toronto, Canada, 11/17/1988
Photodynamic therapy for childhood brain tumors. International Symposium Pediatric Neurosurgery, Santiago, Chile, 09/1995
Futura 2002 Conference. 3rd International Nearfield Optical Analysis. Photobiology Workshop Conference, Sao Paulo, Brazil, 06/2002
10th Annual International Child Neurology Congress Photobiomodulation of Cytochrome Oxidase. Montreal, Canada, 06/2006
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving. Current Perspective -02 Toxicity/HBO/DSRV Experience, 04/2009
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving. Current Perspective -02 Toxicity/HBO/DSRV Experience, 04/2009
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving, 04/2010
Operation Pacific Reach - Singapore Navy. Advances in Submarine Rescue Medicine, 04/2010
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving. Current Perspective -02 Toxicity/HBO/DSRV Experience, 04/2010
Hyperbaric Oxygen for Acute Ischemic Stroke: Need for a Better Study. Near-Infrared Light Therapy: A Phenomenon in Search of a Mechanism, 2nd Polish-American Pediatric Meeting, 05/2010
Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Symposium. Amelioration of Oral Mucositis Pain by NASA Near Infra Red Light Emitting Diodes in Bone Marrow Transplant Patients, 06/2010
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving. Current Perspective -02 Toxicity/HBO/DSRV Experience, 04/2011
Canadian Defense Ministry Diving Medicine Advance. Neurological Conditions and Diving, Current Perspective -02 Toxicity/HBO/DSRV Experience, 04/2011
Harry T. Whelan, M.D., Photodynamic Therapy of Brain Tumors, International Photodynamic Medicine Symposium at OSUCCCC-James, Ohio, 05/2011 - Present
El Salvador Defense Ministry. Sr. Medical Advisor to Command Counter Terrorism Medicine, 06/02/2011
Near-Infrared Pulsating Converging Beam Device for Photodynamic Therapy of Brain Tumors, International Symposia on the Science and Technology of Lighting (LS13), Albany, 06/2012 - Present
Neurological Aspects of Diving Medicine, Canadian Defense Ministry Diving Medicine Advance, 06/2013
Neurological Conditions and Diving Current Perspective –02 Toxicity/HBO/DSRV Experience, Canadian Defense Ministry Diving Medicine Advance, 05/2014
Neurological Conditions and Diving, Canadian Defense Ministry Diving Medicine Advance, 06/2015
Neurologic Aspects of Tactical Combat Casualty Care in Special Operations Diving, Canadian Forces Environmental Medicine Establishment, Toronto, ON, 06/01/2016 - 06/03/2016
Neurological DCI, Canadian Defense Ministry Diving Medicine Advance, Toronto, ON, 05/31/2017 - 06/02/2017
Harry Whelan, Neurological Conditions and Diving & Neurological DCI, Canadian Defense Ministry Diving Medicine Advance, Toronto, Canada, 05/31/2018
 

PROGRAMMATIC DEVELOPMENTS:
 
Research Programs
Biostimulation with Light-Emitting Diodes (LED)
Effects of Near-Infrared light on Cytochrome Oxidase Activity
Therapeutic effects of Near-Infrared Light on Neurologic and Visual System Disorders(i.e.Parkinsons,Leber's Hereditary Optic Atrophy,Laser Eye Injury, Neuronal Apoptosis,Cyanide&Methano Intoxication)
Photodynamic Therapy for Brain Tumors
FDA - approved human studies. Photodynamic Therapy for Brain Tumors; Light-Emitting Diode Wound Healing
In Vitro/ In Vivo Studies of Brain Tumor Biology (Growth Factors, Neuroimaging)
CNS effects of Hyperbaric Pressure and Oxygen
Innate Immunity for Biodefense
NCI-approved human study. Gallium Nitrate for Malignant Solid Tumors of Childhood
Investigation of the therapeutic effects of Near-Infrared Light on Mucositis in Children with Cancer Receiving Bone Marrow Transplant Treatment Protocol
 
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Light being used to treat cancer. CNN. October 1, 1998
2. Major Breakthrough in Treating Children with Brain Cancer: NASA Spin-off Technology Makes it Happen. NASA Satellite Interviews. September 24, 1999
3. First Brain Cancer Surgeries Using New Space-Age Probe Are Successful. NASA News. September 30, 1999
4. Clotting Blood In Zero-G. SpaceDaily. September 23, 1999
5. Space technology may speed healing. MSNBC. October 22, 1999
6. LED's Developed by NASA Used to Ablate Brain Tumors. Oncology News International. January, 2000
7. Healing Rays. Health & Physical Science/Current Science. February 11, 2000
8. From growing plants to killing tumors. Aerospace America. April, 2000
9. NASA-Space Technology Hall of Fame. United States Space Foundation. April 6, 2000
10. Reserve doctor brings life to space age technology. Great Lakes Bulletin. June 2, 2000
11. Navy Medicine takes on NASA for benefits. The Journal National Naval Medical Center. Bethesda, MD. June 15, 2000
12. NASA Space Technology Shines Light on Healing. NASA News. December 18, 2000
13. Medicine-Treatments / Head Light. Beyond 2000. December 20, 2000
14. 2001 The Body in Space - Surviving the Odyssey. National Geographic. January, 2001
15. The Use of NASA Light-Emitting Diode Near-Infrared (IR) Technology for Biostimulation. Futura 2002 Conference. 3rd International Nearfield Optical Analysis. Photobiology Workshop Conference. June 2002
16. Mauk AG, Whelan HT, Taketa F: Holly wreath morphology of feline erythrocytes - the effects of cyanate and 4,4' -dipyridyldisulfide. Proceedings of Society for Experimental Biology & Medicine 1974;145:578-585.
17. Mauk AG, Whelan HT, Putz GR, Taketa F: Anemia in domestic cats: Effects of hemoglobin components and whole blood oxygenation. Science 1974;185:447-449.
18. Antholine W, Knight J, Whelan HT, Petering DH: Studies of the reaction of 2-formylpyridine thiosemicarbason and its iron and copper complexes with biological systems. Molecular Pharmacology 1977;13:89-98.
19. Knight J, Whelan HT, Petering DH: Electronic substituent effects upon properties of 5-substituted-2-formylpyridine thiosemicarbazones and their metal complexes. Journal of Inorganic Biochemistry 1979;11:327-338.
20. Whelan HT, Mehta P: Association of retinoblastoma and acute lymphoblastic leukemia in a family. American Journal of Pediatric Hematology-Oncology 1982;4:37-39.
21. Whelan HT, Hendeles L, Haberkern CM, Neims AH: High intravenous phenytoin dosage requirement in a newborn infant. Neurology, 1983;33:106-1083.
22. Heilman KM, Bower D, Coslett HB, Whelan HT, Watson RT: Prolonged reaction times for leftward movements in patients with right hemisphere lesions and neglect: directional hypokinesia. Neurology 1985;35:855-859.
23. Whelan HT: Neuromuscular syndromes associated with cancer. Comprehensive Therapy 1985;11(9):50-57.
24. Whelan HT, Sung JH, Mastri AR: Diffuse leptomeningeal gliomatosis: Report of three cases. Clinical Neuropathology 1987;6:164-168.
25. Whelan HT, Fogo A, Clinton ME, Smith H: Histiocytosis-x isolated to the cervical spinal cord. American Journal of Pediatric Hematology-Oncology 1987;9(3):228-232.
26. Whelan HT, Clanton JA, Moore P, Tolner DJ, Kessler RW, Whetsell WO: Magnetic resonance brain tumor imaging in canine glioma. Neurology 1987;37:1235-1239.
27. Whelan HT and Moore P: Central nervous system lymphomatoid granulomatosis. Pediatric Neuroscience 1987;13:113-117.
28. Whelan HT, Clanton JA, Wilson RE, Tulipan NB: Comparison of CT and MRI brain tumor imaging using a canine glioma model. Pediatric Neurology 1988;4:279-283.
29. Powers, TA, Partain CL, Kessler RM, Freeman MW, Robertson RH, and Whelan HT: Central nervous system lesions in pediatric patients: Gd-DTPA MRI imaging. Radiology 1988;169:723-726.
30. Whelan HT: Progress in pediatric neuro-oncology. Progress in Clinical Neurosciences 1988;2:201-220.
31. Whelan HT, Pledger WJ, Maciunas RJ, Galloway RL, Whetsell WO, Moses HL: The role of growth factors in the tumorigenicity of a brain tumor cell line. Pediatric Neurology 1989;5:271-279.
32. Whelan HT, Nelson DB, Strother DR, Przybylski C, Figge MS, Mamandi A: Medulloblastoma cell line secretes platelet-derived growth factor. Pediatric Neurology 1989;5:347-352.
33. Maciunas R, Galloway R, Failinger A, Whelan HT: Volumetric measurement of canine gliomas using MRI. Magnetic Resonance Imaging 1990;8:161-165
34. Whelan HT: Medulloblastoma cell line: platelet-derived growth factor secretion. Pediatric Neurology 1990;6:282.
35. Whelan HT, Przybylski C, Chitambar C: Differential effects of gallium nitrate on human brain tumor cells in vitro. Pediatric Neurology 1991;7:23-27.
36. Tang TT, Whelan HT, Meyer GA, Strother DR, Blank EL, Camitta BM, Franciosi RA: Optic chiasm glioma associated with SIADH, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites post ventriculoperitoneal shunting. Child's Nervous System 1991;7:458-461.
37. Whelan HT, Przybylski C, Chitambar C: Alteration of DNA synthesis in human brain tumor cells by gallium nitrate in vitro. Pediatric Neurology 1991;7:352-354.
38. D'Cruz O, Whelan HT: Breathholding Spells and Esophageal Foreign Body. Clinical Pediatrics 1991;30:295-296.
39. Whelan HT, Traul D, Segura A, Przybylski C, Meyer GA, Sieber, F: Interactions of merocyanine 540 with human brain tumor cells: Preferential binding in vitro and dye- sensitized photoinactivation in vivo. Pediatric Neurology 1992;8:117-120.
40. Whelan HT, Schmidt MH, Anderson GS, Chan BK, Hunter K, Kubacki D, Segura AD and Chitambar CR: Antineoplastic effects of gallium nitrate on human medulloblastoma in vivo. Pediatric Neurology 1992;8(5):323-327.
41. Whelan HT, Przybylski C, Bajic DM, Schmidt MH: Intracellular Growth Factor Metabolism in Proliferation of a Brain Tumor Cell Line. Journal of Neuro-Oncology 1993;15:243-250.
42. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer, GA: The role of photodynamic therapy in posterior fossa brain tumors: A pre-clinical study in a canine glioma model. Journal of Neurosurgery 1993;79:562-568.
43. Petering DH, Quesada A, Dughish M, Krull S, Gan T, Whelan HT: Metallothionein in tumor and host: Interactions of zinc metabolism, stress response and tumor therapy. Metallothionein 1993;3:329-346.
44. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA: Photodynamic therapy. Journal of Neurosurgery 1994;80:774-75.
45. Whelan HT, Williams MB, Bajic DM, Segura AD, McAuliffe TL, Chitambar CR: Prevention of gallium toxicity by hyperhydration in treatment of medulloblastoma. Pediatric Neurology 1994;10:217-220.
46. Whelan HT, Williams MB, Bajic DM, Flores RE, Schmidt MH, McAuliffe TL, Chitambar CR: Gallium nitrate delays progression of microscopic disease in a human medulloblastoma murine model. Pediatric Neurology 1994;11:44-46.
47. Whelan HT, Kras LH, Ozker K, Bajic DM, Schmidt MH, Liu Y, Trembath LA, Uzum F, Meyer GA, Segura AD, Collier BD: Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo. Journal of Neuro-Oncology 1994;22:7-13.
48. Schmidt MH, Bajic DM, Reichert KW, Martin TS, Meyer GA,Whelan HT: Light-emitting diodes as a light source for intra-operative photodynamic therapy. Neurosurgery 1996;38:552-7.
49. Schmidt MH. Bajic DM, Reichert KW, Meyer GA, Martin TS,Whelan HT: The role of light-emitting diodes for photodynamic therapy of brain tumors. Space Technology Appl. 1996;361:403-12.
50. Whelan HT, Bajic DM, Kindwall EP: Use of CYT-P450 mono-oxygenase inhibitors to alter seizures caused by central nervous system oxygen toxicity. Report to OIC-NAVDIVESALVTRACEN-DET-COMSUBPAC 1996;1-18.
51. Whelan HT, Kindwall EP: Hyperbaric oxygen: some unanswered questions despite clinical usefulness. In: Hudetz AG, Bruley D, eds. Oxygen Transport to Tissue XX. Advances in Experimental Medicine and Biology: Vol. 454, Plenum Publishing, New York, 1998.
52. Kupst MJ, Strother D, Penati B, Camitta B, Meyer GM, Murray K, Whelan HT: Child & family coping with Pediatric CNS tumors. Pediatric. Psychol. 1998.
53. Whelan HT, Bajic DM, Karlovits SM, Houle JM, Kindwall EP: Use of Cytochrome-P450 monooxygenase 2 E1 isozyme inhibitors to alter seizures caused by central nervous system oxygen toxicity. Aviation, Space, and Environmental Medicine. 1998;60:480-485.
54. Whelan HT, Houle JM, Bajic DM, Schmidt MH, Reichert KW II, Meyer GA: Benzoporphyrin derivative and light-emitting diode for use in photodynamic therapy: applications of space light-emitting diode technology. Space Technology Applications. 1998;420:729-735.
55. Whelan HT, Krouwer HG, Schmidt MH, Kovnar EH: Current therapy and new perspectives in the treatment of medulloblastoma. Pediatric Neurology. 1998;18:103-115.
56. Whelan HT, Houle JM, Donohoe DL, Bajic DM, Schmidt MH, Reichert KW, Weyenberg GT, Larson DL, Meyer GA, Caviness JA: Medical applications of space light-emitting diode technology - space station and beyond. Space Technology Applications. 1999;458:3-15.
57. Schmidt MH, Reichert KW, Ozker K, Meyer GA, Donohoe DL, Bajic DM, Whelan NT, Whelan HT: Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors. Pediatric Neurosurgery. 1999; 30(5):225-231.
58. Whelan HT, Houle BS, Donohoe DL, Whelan NT, Cwiklinski J, Schmidt MH, Larson DL, Meyer GA, Cevenini V, Stinson H: The NASA light-emitting diode medical program - progress in space flight and terrestrial applications. Space Technology Applications. 2000;504:37-43.
59. Whelan HT, Buchmann EV, Whelan NT, Turner SG, Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Meyer GA, Hodgson B, Gould L, Kane M, Chen G, Caviness J: NASA Light-Emitting Diode Medical Applications From Deep Space to Deep Sea. Space Technology Applications. 2001;552:35-45.
60. Sommer AP, Pinheiro ALB, Mester AR, Franke RP, Whelan HT: Biostimulatory Windows in Low Intensity Laser Activation: Lasers, Scanners and NASA's Light Emitting Diode Array System. Journal of Clinical Laser Medicine and Surgery. 2001;19:29-33.
61. Whelan HT, Smits RL, Buchmann EV, Whelan NT, Turner SG, Margolis DA, Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J: Effect of NASA Light-Emitting Diode (LED) Irradiation on Wound Healing. Journal of Clinical Laser Medicine and Surgery. 2001;19:305-314.
62. Whelan HT, Smits, Jr. RL, Buchmann, EV, Whelan, NT, Turner, SG, Cevenini, V, Stinson, H, Ignatius, R, Martin, T, Cwiklinski, J, Philippi, AF, Graf, M, Hodgson, B, Gould, L, Kane, M, Chen, G, Caviness, J: Effect of NASA Light-Emitting Diodes (LED) In Conjunction With HBOT On Wound Healing. Hyperbaric Medicine Today. 2001;1:16-19
63. Wong-Riley MTT, Bai X, Buchmann E, Whelan HT: Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. NeuroReport(Neurochemistry). 2001;12:3033-3037.
64. Whelan HT, Wong-Riley MTT, and Eells JT: Protection against methanol-induced retinal toxicity by LED photostimulation. Progress in Biomedical Optics and Imaging. Society of Photo-Optical Instrumentation Engineers, 2002; 4611: 239-246.
65. Whelan HT, Connelly JF, Hodgson BD, Barbeau L, Post AC, Bullard G, Buchmann EV, Kane M, Whelan NT, Warwick A, Margolis D: NASA Light-Emitting Diodes for the Prevention of Oral Mucositis in Pediatric Bone Marrow Transplant Patients. Journal of Clinical Laser Medicine & Surgery 2002; 20:319-324.
66. Whelan HT, Buchmann EV, Dhokalia A, Kane M, Whelan N, Wong-Riley MTT, Eells J, Gould LJ, Hammamieh R, Das R, Jett M: Effect of NASA Light-Emitting Diode (LED) Irradiation on Molecular changes for Wound Healing in Diabetic Mice. Journal of Clinical Laser Medicine & Surgery, 2003; 21:67-74.
67. Eells JT, Henry MM, Summerfelt P, Wong-Riley MTT, Buchmann E, Kane M, Whelan NT, Whelan HT: Therapeutic photobiomodulation for methanol induced retinal toxicity. Proceedings of the National Academy of Sciences, USA - 2003; 100:3439-3444.
68. Sommer AP, Oron U, Pretorius AM, McKay D, Ciftcioglu N, Mester A, Kajander EO, Whelan HT: A Preliminary Investigation into Light-Modulated Replication of Nanobacteria and Heart Disease. Journal of Clinical Laser Medicine & Surgery, 2003; 21:231-235.
69. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT: Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. Journal of NeuroOncology, 2004; 67:201-204.
70. Whelan HT, Hale-Richlen BL, Pharaon MR, Henry KA: Soldier Self Care. Military Medical Technology, 2004; 8:4-9.
71. Whelan HT, Wong-Riley MMT, Eells JT, VerHoeve JT, Das R, Jett M: DARPA Soldier Self Care, Rapid Healing of Laser Eye Injuries with Light Emitting Diodes. NATO Research and Technology Organization, 2004; Publication RTO-MP-HFM-109-P19.
72. Eells JT, Wong-Riley MTT, Verhoeve J, Henry M, Buchmann EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson B, Margolis D, Whelan HT: Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion, 2004; 4:559-568.
73. Wong-Riley MMT, Eells JT, Whelan HT: Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. Journal of Biological Chemistry, 2005; 280:4761 - 4771.
74. Yeager RL, Franzosa JA, Millsap DS, Angell-Yeager JL, Heise SS, Wakhungu P, Lim J, Whelan HT, Eells JT, Henshel DS: Effects of 670-nm phototherapy on development. Photomed Laser Surg. 2005;23:268-72.
75. Whelan HT: Innate Immunity for Biodefense: A Strategy Whose Time Has Come. Journal of Allergy and Clinical Immunology, 2005; 116:1334-42.
76. Helms AK, Whelan HT, Torbey MT: Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovascular Diseases, 2005;20:417-426.
77. Whelan HT, Niezgoda JA, Kindwall EP, Cabigas B, Lewis MC: Hyperbaric oxygenation. Encyclopedia of Medical Devices and Instrumentation, Second Edition. John G.Webster ,Ed. Wiley-Interscience, 2006;4:29-33.
78. Sommer AP, Gheorghiu E, Cehreli M, Whelan HT: Biosensor for detection of nanobacteria in water. Crystal Growth & Design, 2006;6:492-497.
79. Liang HL, Whelan HT, Eells JT, Meng H, Buchmann E, Lerch-Gaggl, Wong-Riley M: Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis. Neuroscience. 2006;139:639 - 649.
80. Yeager RL, Franzosa JA, Millsap DS, Lim J, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS: Survivorship and mortality implications of developmental 670-nm phototherapy: Dioxin Co-exposure; Photomed Laser Surg. 2006;24:29-32
81. Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS, Yeager RL, Milsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT: Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006;24:121-128.
82. Whelan HT: Photobiomodulation of cytochrome oxidase; Proceedings of the 10th International Child Neurology Congress.2006; 207-214.
83. Ninomiya JT, Hunter JG, Miller SR, Dixon AE, Buchmann EV, Whelan HT: Near Infrared Light Irradiation Alters Osteoblast Maturation and the Expression and Secretion of Bone Proteins.
84. Whelan HT, Eells J, Wong-Riley M, Das R, Jett M, VerHoeve J: Photomodulation of Cytochrome Oxidase Annals of Neurology. 2006;60. (S10):S143 (49).
85. Whelan HT: Photomodulation of Cytochrome Oxidase. Neuropediatrics. 2006;37. (S1):MP83. Accessed online at http://www.thieme-connect.com/ejournals/toc/neuropediatrics DOI: 10.1055/s-2006-943680.
86. Yeager RL, Franzosa JA, Millsap DS, Lim J, Hansen CM, Jasevicius AV, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS: Brief report: embryonic growth and hatching implications of developmental 670-nm phototherapy and dioxin co-exposure. Photomedicine and Laser Surgery. 24(3):410-3, 2006 Jun.
87. Yeager RL, Franzosa JA, Millsap DS, Lim J, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS: Survivorship and mortality implications of developmental 670-nm phototherapy: dioxin co-exposure. Photomedicine and Laser Surgery. 24(1):29-32, 2006 Feb.
88. Helms AK, Whelan HT, Torbey MT: Hyperbaric oxygen therapy of acute ischemic stroke. Stroke. 38(4):1137; author reply 1138-9, 2007 Apr.
89. Helms AK, Whelan HT: Hyperbaric Oxygen for Acute Ischemic Stroke: Need for a Better Study. Undersea and Hyperbaric Medicine 34:275, 2007.
90. Dituri J, Parsley K, Whelan HT: Lightweight, Faster Decompression and Portable Alternative to U.S. Navy Mixed Gas Diving. Undersea and Hyperbaric Medicine 34:255, 2007.
91. Whelan HT, Cook JD, Hovinga CA, Chan AF, Ichord RN, deVeber GA, Thall PF; Practical model-based dose-finding in early phase clinical trials: Optimizing tPA dose for treatment of ischemic stroke in children; STROKE 2008, 39:2627-2636.
92. Whelan HT, Desmet K, Buchmann E, Henry M, Wong-Riley M, Eells JT, Verhoeve J: Harnessing the cell's own ability to repair and prevent neurodegenerative disease. SPIE 2008, Accessed on line at: http://spie.org/documents/Newsroom/Imported/1014/1014-2008-02-11.pdf
93. Liang HL, Whelan HT, Eells JT, Wong-Riley M: Near-Infrared Light via Light-Emitting Diode Treatment is Therapeutic Against Rotenone- and MPP+- Induced Neurotoxicity. Neuroscience 153(4)963-974, 2008.
94. Whelan HT, Cook JD, Hovinga CA, Chan AK, Ichord RN, deVeber GA, Thall PF: Practical Model-Based Dose-Finding in Early Phase Clinical Trials: Optimizing tPA Dose For Treatment Of Ischemic Stroke In Children. (January 2008). UT MD Anderson Cancer Center Department of Biostatistics Working Paper Series. Working Paper 41. http://www.bepress.com/mdandersonbiostat/paper41
95. Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT: Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+- induced neurotoxicity, Brain Research 2008, 1243:167-173.
96. Dituri J, Parsley K, Whelan HT: Could the U.S. Navy Benefit from Technical Diving Techniques? Undersea and Hyperbaric Medicine 35:250-251, 2008.
97. Zhang R, Mio Y, Pratt PF, Lohr NL, Warltier DC, Whelan HT, Zhu D, Jacobs ER, Medhora M, Bienengraeber M: Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. Journal of Molecular and Cellular Cardiology. 18930064 (P,S,G,E,B,D), 2008
98. Hymer WC, Welsch J, Buchmann E, Risius M, Whelan HT: Modulation of rat pituitary growth hormone by 670 nm light. Growth Hormone & IGF Research, 19:274-279, 2009
99. Whelan HT, Desmet KD, Buchmann EV, Henry M, Wong-Riley MTT, Eells JT, VerHoeve J: Harnessing the cell's own ability to repair and prevent neurodegenerative disease. Annals of Neurology 64:S91,2008.
100. DeSmet K, Buchmann E, Henry M, Wong-Riley M, Eells J, VerHoeve J, Whelan HT: Near-infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury. SPIE 2009
101. Whelan HT, Srivatsal S: The Proverbial light at the end of the tunnel in brain tumor treatment. SPIE 2009
102. Helms, A, Evans, AW, Chu, J, Sahgal, A, Ostrowski, R, Sosiak,T, Wolf, G, Gillett, J, Whelan, H.T. Hyperbaric oxygen for neurologic indications: Action plan for multicenter trials in: stroke, traumatic brain injury, radiation encephalopathy & status migrainosus. Undersea Hyperb Med, 2011
103. Zhang R, Mio Y, Pratt PF, Lohr N, Warltier DC, Whelan HT, Zhu D, Jacobs ER, Medhora M, Bienengraeber M. Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. J Mol Cell Cardiol. 2009 Jan;46(1):4-14. Epub 2008 Sep 30.
104. Henry MM, Stowe DF, Heisner JS, Rao R, Dhala A, Camara AKS, Whelan HT. Photobiomodulation reduces perilesional myocardial injury during radiofrequency ablation in guinea pig hearts. The FASEB Journal, 2009
105. Hodgson,B., Margolis,D.M.,Salzman,D.E, Eastwood,D., Tarima, S., Williams,L.D., Sande,J., Vaughn,W.P., Whelan,H.T. Amelioration of Oral Mucositis Pain by NASA Near Infra Red Light Emitting Diodes in Bone Marrow Transplant Patients, Supportive Care in Cancer. 2011
106. Allen, S., Kilian, C., Phelps, J., Whelan, H.T. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Supportive Care Cancer. 2012.
107. DeSmet D, Henry MM, Buchmann EV, Jansen A, Blindauer K, Wong-Riley M, Eells JT, Whelan, HT. Near-Infrared Photobiomodulation Attenuates Disease Onset and Progression in a Transgenic Mouse Model of Parkinson's Disease. Experimental Neurology, 2011 In Press
108. Quirk B., DeSmet K., Henry M., Buchmann, E., Wong-Riley M.,Eells, J., Whelan HT. Therapeutic effect of near infrared (NIR) light on Parkinson's disease models in vitro and in vivo. Frontiers of Bioscience, 2012
109. Hodgson B, Pyzcka B, Buchmann EV, Henry MM, Whelan, HT. Effect of Photobiomodulation on Vinblastine Poisoned Murine HERS Cells. PMLS, 29;143-144, 2011.
110. Rietema, E., Whelan, H.T. Near Infrared Pulsating Converging Beam Device for Photodynamic Therapy of Brain Tumors. Proceedings 13th International Symposium on the Science and Technology of Lighting. 289-295, June 2012
111. Quirk,B., Torbey, M., Buchmann, E., Verma,S., Whelan, H.T. Near-Infrared Photobiomodulation in an Animal Model of Traumatic Brain Injury: Improvements at the Behavioral and Biochemical Levels. Photomedicine and Laser Surgery 30(9) 2012.
112. Petrov,G., Doronin,A., Whelan, H.T., Meglinski,I., Yakovlev1, V. Human tissue color as viewed in high dynamic range optical spectral transmission measurements. Biomedical Optics Express, 3 (9)Sept 2012.
113. Whelan, H.T. High-Grade Glioma/Glioblastoma Multiforme: Is There a Role for Photodynamic Therapy? JNCCN 2012
114. Willoughby, R., Verma, S., Landisch, R., Schmainda, K., Prah, M., Quirk, B. Whelan, H.T. Presumed hydrogen sulfide-mediated neurotoxicity following Streptococcus anginosus group meningitis. Pediatr Infect Dis 2013.
115. Whelan, H.T, Verma, S., Guo, Y., Thabet, F., Bozarth, X., Nwosu, M., Katyayan, A., Parachuri, V., Spangler, K., Ruggeri, B., Srivatsal, S., Zhang, G., Ashwal, S. Evaluation of the Child With Acute Ataxia: A Systematic Review. Pediatric Neurology, 2013;49(1):15-24
116. Valadão, J., Pearl, J., Verma, S., Helms, A., Whelan, H.T. Hyperbaric oxygen treatment for post-radiation central nervous system injury: A retrospective case series. UHM 2014;41(2) : 87- 96.
117. Seidel, R., Carroll, C., Thompson, D., Diem, R., Yeboah, K., Hayes, A.J., Hall, B., Whelan, H.T. Risk factors for oxygen toxicity seizures in hyperbaric oxygen therapy: Case reports from multiple institutions. UHM 2014;40(6) : 515-519.
118. Whelan, H.T, Annis, H., Guajardo, P. From Land to Sea; Embracing a Renewable Future. J Biotechnol Biomater 2014, S6.
119. Valadao, J., Annis, H., O’Connor, S., Vigilante, j., DiGeorge, N., Bear, A., Kenyon, J., Dituri, J., Dituri, A., Whelan, H.T. Ketogenic diet for high partial pressure oxygen diving. UHM 2014;40(5).
120. Valadão, J., Pearl, J., Verma, S., Helms, A., Whelan, H.T. Hyperbaric oxygen treatment for post-radiation central nervous system injury: A retrospective case series. UHM 2014;41(2) : 87- 96.
121. Whelan, H.T, Annis, H., Guajardo, P. From Land to Sea; Embracing a Renewable Future. J Biotechnol Biomater 2014, S6.
122. Valadao, J., Annis, H., O’Connor, S., Vigilante, j., DiGeorge, N., Bear, A., Kenyon, J., Dituri, J., Dituri, A., Whelan, H.T. Ketogenic diet for high partial pressure oxygen diving. UHM 2014;40(5).
123. Martin R, Srivastava T, Lee J, Raj N, Koth KA, Whelan HT. Using hyperbaric oxygen for autism treatment: A review and discussion of literature. Undersea Hyperb Med. 2015 Jul-Aug;42(4):353-9.
124. Sannagowdara K, Willoughby R, Whelan H. Proton Nuclear Magnetic Resonance (NMR) Metabolomics: Future in Etiological Diagnosis of Encephalomyelitis. J Neuroinfect Dis. 2015 Aug;6(3). PMCID: PMC4556357
125. Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT. Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? Photodiagnosis Photodyn Ther. 2015 Sep;12(3):530-44.
126. Bumah VV, Whelan HT, Masson-Meyers DS, Quirk B, Buchmann E, Enwemeka CS. The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA). Lasers Med Sci. 2015 Apr;30(3):1153-9. PMCID: PMC4535990
127. Moon SH, Baek SO, Jung SN, Seo BF, Lee DC, Kwon H. Efficacy of biodegradable synthetic polyurethane foam for packing nasal bone fractures. J Craniofac Surg. 2012 Nov;23(6):1848-50.
128. Monrad P, Sannagowdara K, Bozarth X, Bhosrekar S, Hecox K, Nwosu M, Schwabe M, Meyer M, Szabo A, Prigge J, Lemke R, Horn B, Whelan HT. Haemodynamic response associated with both ictal and interictal epileptiform activity using simultaneous video electroencephalography/near infrared spectroscopy in a within-subject study. J Near Infrared Spectrosc. 2015;23(4):209-218. PMCID: PMC4629858
129. Valadão J, Pearl J, Verma S, Helms A, Whelan H. Hyperbaric oxygen treatment for post-radiation central nervous system injury: a retrospective case series. Undersea Hyperb Med. 2014 Mar-Apr;41(2):87-96.
130. Valadao JM, Vigilante JA, DiGeorge NW, O'Connor SE, Bear A, Kenyon J, Annis H, Dituri J, Dituri AE, Whelan HT. Ketogenic diet for high partial pressure oxygen diving. Undersea Hyperb Med. 2014 Jul-Aug;41(4):331-5.
131. Seidel R, Carroll C, Thompson D, Diem RG, Yeboah K, Hayes AJ, Hall B, Whelan HT. Risk factors for oxygen toxicity seizures in hyperbaric oxygen therapy: case reports from multiple institutions. Undersea Hyperb Med. 2013 Nov-Dec;40(6):515-9.
132. Quirk BJ, Torbey M, Buchmann E, Verma S, Whelan HT. Near-infrared photobiomodulation in an animal model of traumatic brain injury: improvements at the behavioral and biochemical levels. Photomed Laser Surg. 2012 Sep;30(9):523-9. PMCID: PMC3423868
133. Petrov GI, Doronin A, Whelan HT, Meglinski I, Yakovlev VV. Human tissue color as viewed in high dynamic range optical spectral transmission measurements. Biomed Opt Express. 2012 Sep 01;3(9):2154-61. PMCID: PMC3447557
134. Allen S, Kilian C, Phelps J, Whelan HT. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Support Care Cancer. 2012 Oct;20(10):2467-72.
135. Quirk BJ, Sonowal P, Jazayeri MA, Baker JE, Whelan HT. Cardioprotection from ischemia-reperfusion injury by near-infrared light in rats. Photomed Laser Surg. 2014 Sep;32(9):505-11. PMCID: PMC4142831
136. Whelan HT, Verma S, Guo Y, Thabet F, Bozarth X, Nwosu M, Katyayan A, Parachuri V, Spangler K, Ruggeri BE, Srivatsal S, Zhang G, Ashwal S. Evaluation of the child with acute ataxia: a systematic review. Pediatr Neurol. 2013 Jul;49(1):15-24.
137. Whelan HT. High-grade glioma/glioblastoma multiforme: is there a role for photodynamic therapy? J Natl Compr Canc Netw. 2012 Oct 01;10 Suppl 2:S31-4.
138. Verma S, Landisch R, Quirk B, Schmainda K, Prah M, Whelan HT, Willoughby RE Jr. Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis. Pediatr Infect Dis J. 2013 Feb;32(2):189-91. PMCID: PMC3548939
139. Quirk BJ, Desmet KD, Henry M, Buchmann E, Wong-Riley M, Eells JT, Whelan HT. Therapeutic effect of near infrared (NIR) light on Parkinson's disease models. Front Biosci (Elite Ed). 2012 Jan 01;4:818-23.
140. Whelan HT, Przybylski C, Bajic DM, Schmidt MH. Intracellular growth factor metabolism in proliferation of a brain tumor cell line. Intracellular growth factors and brain tumor proliferation. J Neurooncol. 1993 Mar;15(3):243-50.
141. Whelan HT, Bajic DM, Karlovits SM, Houle JM, Kindwall EP. Use of cytochrome-P450 mono-oxygenase 2 E1 isozyme inhibitors to delay seizures caused by central nervous system oxygen toxicity. Aviat Space Environ Med. 1998 May;69(5):480-5.
142. Hodgson BD, Margolis DM, Salzman DE, Eastwood D, Tarima S, Williams LD, Sande JE, Vaughan WP, Whelan HT. Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer. 2012 Jul;20(7):1405-15.
143. Hymer WC, Welsch J, Buchmann E, Risius M, Whelan HT. Modulation of rat pituitary growth hormone by 670 nm light. Growth Horm IGF Res. 2009 Jun;19(3):274-9.
144. Quirk BJ, Whelan HT. Near-infrared irradiation photobiomodulation: the need for basic science. Photomed Laser Surg. 2011 Mar;29(3):143-4. PMCID: PMC3048832
145. Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity. Brain Res. 2008 Dec 03;1243:167-73. PMCID: PMC3706077
146. Zhang R, Mio Y, Pratt PF, Lohr N, Warltier DC, Whelan HT, Zhu D, Jacobs ER, Medhora M, Bienengraeber M. Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. J Mol Cell Cardiol. 2009 Jan;46(1):4-14. PMCID: PMC2640422
147. Whelan HT, Cook JD, Amlie-Lefond CM, Hovinga CA, Chan AK, Ichord RN, Deveber GA, Thall PF. Practical model-based dose finding in early-phase clinical trials: optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children. Stroke. 2008 Sep;39(9):2627-36.
148. Liang HL, Whelan HT, Eells JT, Wong-Riley MT. Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. Neuroscience. 2008 Jun 02;153(4):963-74. PMCID: PMC2587428
149. Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of acute ischemic stroke. Stroke. 2007 Apr;38(4):1137; author reply 1138-9.
150. Yeager RL, Lim J, Millsap DS, Jasevicius AV, Sanders RA, Whelan HT, Watkins JB 3rd, Eells JT, Henshel DS. 670 nanometer light treatment attenuates dioxin toxicity in the developing chick embryo. J Biochem Mol Toxicol. 2006;20(6):271-8.
151. Yeager RL, Franzosa JA, Millsap DS, Lim J, Hansen CM, Jasevicius AV, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS. Brief report: embryonic growth and hatching implications of developmental 670-nm phototherapy and dioxin co-exposure. Photomed Laser Surg. 2006 Jun;24(3):410-3.
152. Yeager RL, Franzosa JA, Millsap DS, Lim J, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS. Survivorship and mortality implications of developmental 670-nm phototherapy: dioxin co-exposure. Photomed Laser Surg. 2006 Feb;24(1):29-32.
153. Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS, Yeager RL, Millsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006 Apr;24(2):121-8.
154. Amlie-Lefond C, Paz DA, Connelly MP, Huffnagle GB, Whelan NT, Whelan HT. Innate immunity for biodefense: a strategy whose time has come. J Allergy Clin Immunol. 2005 Dec;116(6):1334-42.
155. Liang HL, Whelan HT, Eells JT, Meng H, Buchmann E, Lerch-Gaggl A, Wong-Riley M. Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis. Neuroscience. 2006 May 12;139(2):639-49.
156. Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion. 2004 Sep;4(5-6):559-67.
157. Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis. 2005;20(6):417-26.
158. Yeager RL, Franzosa JA, Millsap DS, Angell-Yeager JL, Heise SS, Wakhungu P, Lim J, Whelan HT, Eells JT, Henshel DS. Effects of 670-nm phototherapy on development. Photomed Laser Surg. 2005 Jun;23(3):268-72.
159. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol. 2004 Mar-Apr;67(1-2):201-7.
160. Hodgson BD, Pyszka B, Henry MM, Buchmann E, Whelan HT. Effect of photobiomodulation on vinblastine-poisoned murine HERS cells. Photomed Laser Surg. 2011 Apr;29(4):233-7.
161. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem. 2005 Feb 11;280(6):4761-71.
162. Whelan HT, Buchmann EV, Dhokalia A, Kane MP, Whelan NT, Wong-Riley MT, Eells JT, Gould LJ, Hammamieh R, Das R, Jett M. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. J Clin Laser Med Surg. 2003 Apr;21(2):67-74.
163. Whelan HT, Connelly JF, Hodgson BD, Barbeau L, Post AC, Bullard G, Buchmann EV, Kane M, Whelan NT, Warwick A, Margolis D. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg. 2002 Dec;20(6):319-24.
164. Whelan HT, Smits RL Jr, Buchman EV, Whelan NT, Turner SG, Margolis DA, Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J. Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg. 2001 Dec;19(6):305-14.
165. Sommer AP, Pinheiro AL, Mester AR, Franke RP, Whelan HT. Biostimulatory windows in low-intensity laser activation: lasers, scanners, and NASA's light-emitting diode array system. J Clin Laser Med Surg. 2001 Feb;19(1):29-33.
166. Wong-Riley MT, Bai X, Buchmann E, Whelan HT. Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. Neuroreport. 2001 Oct 08;12(14):3033-7.
167. Eells JT, Henry MM, Summerfelt P, Wong-Riley MT, Buchmann EV, Kane M, Whelan NT, Whelan HT. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3439-44. PMCID: PMC152311
168. Sommer AP, Oron U, Pretorius AM, McKay DS, Ciftcioglu N, Mester AR, Kajander EO, Whelan HT. A preliminary investigation into light-modulated replication of nanobacteria and heart disease. J Clin Laser Med Surg. 2003 Aug;21(4):231-5.
169. Schmidt MH, Reichert KW 2nd, Ozker K, Meyer GA, Donohoe DL, Bajic DM, Whelan NT, Whelan HT. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors. Pediatr Neurosurg. 1999 May;30(5):225-31.
170. Schmidt MH, Bajic DM, Reichert KW 2nd, Martin TS, Meyer GA, Whelan HT. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery. 1996 Mar;38(3):552-6; discussion 556-7.
171. Whelan HT, Kindwall EP. Hyperbaric oxygen. Some unanswered questions despite clinical usefulness. Adv Exp Med Biol. 1998;454:441-5.
172. Whelan HT, Krouwer HG, Schmidt MH, Reichert KW, Kovnar EH. Current therapy and new perspectives in the treatment of medulloblastoma. Pediatr Neurol. 1998 Feb;18(2):103-15.
173. Whelan HT, Williams MB, Bajic DM, Segura AD, McAuliffe TL, Chitambar CR. Prevention of gallium toxicity by hyperhydration in treatment of medulloblastoma. Pediatr Neurol. 1994 May;10(3):217-20.
174. Whelan HT, Kras LH, Ozker K, Bajic D, Schmidt MH, Liu Y, Trembath LA, Uzum F, Meyer GA, Segura AD. Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo. J Neurooncol. 1994;22(1):7-13.
175. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA. The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurg. 1993 Oct;79(4):562-8.
176. Whelan HT, Williams MB, Bajic DM, Flores RE, Schmidt MH, McAuliffe TL, Chitambar CR. Gallium nitrate delays the progression of microscopic disease in a human medulloblastoma murine model. Pediatr Neurol. 1994 Jul;11(1):44-6.
177. Whelan HT, Hendeles L, Haberkern CM, Neims AH. High intravenous phenytoin dosage requirement in a newborn infant. Neurology. 1983 Jan;33(1):106-8.
178. Mauk AG, Whelan HT, Taketa F, Fujimoto JM. "Holly wreath" morphology of feline erythrocytes--the effects of cyanate and 4,4'-dipyridyldisulfide. Proc Soc Exp Biol Med. 1974 Feb;145(2):578-85.
179. Mauk AG, Whelan HT, Putz GR, Taketa F. Anemia in domestic cats: effect on hemoglobin components and whole blood oxygenation. Science. 1974 Aug 02;185(4149):447-9.
180. Whelan HT, Sung JH, Mastri AR. Diffuse leptomeningeal gliomatosis: report of three cases. Clin Neuropathol. 1987 Jul-Aug;6(4):164-8.
181. Whelan HT, Clanton JA, Moore PM, Tolner DJ, Kessler RM, Whetsell WO Jr. Magnetic resonance brain tumor imaging in canine glioma. Neurology. 1987 Jul;37(7):1235-9.
182. Whelan HT, Clinton ME, Fogo A, Smith H. Histiocytosis-X isolated to the cervical spinal cord. Am J Pediatr Hematol Oncol. 1987;9(3):228-32.
183. Whelan HT, Moore P. Central nervous system lymphomatoid granulomatosis. Pediatr Neurosci. 1987;13(3):113-7.
184. Whelan HT, Clanton JA, Wilson RE, Tulipan NB. Comparison of CT and MRI brain tumor imaging using a canine glioma model. Pediatr Neurol. 1988 Sep-Oct;4(5):279-83.
185. Whelan HT, Przybylski C, Chitambar CR. Differential effects of gallium nitrate on proliferation of brain tumor cells in vitro. Pediatr Neurol. 1991 Jan-Feb;7(1):23-7.
186. D'Cruz OF, Whelan HT. Breathholding spells and esophageal foreign body. Clin Pediatr (Phila). 1991 May;30(5):295-6.
187. Whelan HT. Neuromuscular syndromes associated with cancer. Compr Ther. 1985 Sep;11(9):50-7.
188. Powers TA, Partain CL, Kessler RM, Freeman MW, Robertson RH, Wyatt SH, Whelan HT. Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging. Radiology. 1988 Dec;169(3):723-6.
189. Whelan HT, Pledger WJ, Maciunas RJ, Galloway RL Jr, Whetsell WO Jr, Moses HL. Growth factors in the tumorigenicity of a brain tumor cell line. Pediatr Neurol. 1989 Sep-Oct;5(5):271-9.
190. Whelan HT, Schmidt MH, Anderson GS, Chan BK, Hunter K, Kubacki D, Segura AD, Chitambar CR. Antineoplastic effects of gallium nitrate on human medulloblastoma in vivo. Pediatr Neurol. 1992 Sep-Oct;8(5):323-7.
191. Whelan HT, Przybylski C, Chitambar CR. Alteration of DNA synthesis in human brain tumor cells by gallium nitrate in vitro. Pediatr Neurol. 1991 Sep-Oct;7(5):352-4.
192. Whelan HT, Traul DL, Przybylski C, Segura A, Thomas J, Meyer G, Sieber F. Interactions of merocyanine 540 with human brain tumor cells. Pediatr Neurol. 1992 Mar-Apr;8(2):117-20.
193. Whelan HT, Nelson DB, Strother D, Przybylski C, Figge G, Mamandi A. Medulloblastoma cell line secretes platelet-derived growth factor. Pediatr Neurol. 1989 Nov-Dec;5(6):347-52.
194. Galloway RL Jr, Maciunas RJ, Failinger AL, Whelan HT. Volumetric measurement of canine gliomas using MRI. Magn Reson Imaging. 1990;8(2):161-5.
195. Whelan HT. Medulloblastoma cell line. Pediatr Neurol. 1990 Jul-Aug;6(4):282.
196. Tang TT, Whelan HT, Meyer GA, Strother DR, Blank EL, Camitta BM, Franciosi RA. Optic chiasm glioma associated with inappropriate secretion of antidiuretic hormone, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites following ventriculoperitoneal shunting. Childs Nerv Syst. 1991 Dec;7(8):458-61.
197. Whelan HT, Annis H, Guajardo P. From Land to Sea; Embracing a Renewable Future. J Biotechnol Biomater. 2014;Suppl 6. PMCID: PMC4803031
198. Dituri J, Sadler R, Siddiqi F, Sadler C, Javeed N, Annis H, Whelan H. Echocardiographic evaluation of intracardiac venous gas emboli following in-water recompression. Undersea Hyperb Med. 2016 Mar-Apr;43(2):103-12.
199. Quirk BJ, Whelan HT. Effect of Red-to-Near Infrared Light on the Reaction of Isolated Cytochrome c Oxidase with Cytochrome c. Photomed Laser Surg. 2016 Dec;34(12):631-637.
200. Quirk BJ, Sannagowdara K, Buchmann EV, Jensen ES, Gregg DC, Whelan HT. Effect of near-infrared light on cellular ATP production of osteoblasts and fibroblasts and on fracture healing with intramedullary fixation. J Clin Orthop Trauma. 2016 Oct-Dec;7(4):234-241. PMCID: PMC5106470
201. Whelan H, Harmelink M, Chou E, Sallowm D, Khan N, Patil R, Sannagowdara K, Kim JH, Chen WL, Khalil S, Bajic I, Keval A, Greydanus D. Complex febrile seizures-A systematic review. Dis Mon. 2017 Jan;63(1):5-23.
202. Quirk BJ, Girotti AW, Whelan HT. Is Photodynamic Therapy Resistance a Special Case of Photobiomodulation? Photomed Laser Surg. 2018 08;36(8):397-398.
203. Kadamati P, Sugar JJ, Quirk BJ, Mehrvar S, Chelimsky GG, Whelan HT, Chelimsky TC, Ranji M. Near-infrared spectroscopy muscle oximetry of patients with postural orthostatic tachycardia syndrome. J Innov Opt Health Sci. 2018 Sep;11(6). PMCID: PMC6124683
204. Antholine WE, Vasquez-Vivar J, Quirk BJ, Whelan HT, Wu PK, Park JI, Myers CR. Treatment of Cells and Tissues with Chromate Maximizes Mitochondrial 2Fe2S EPR Signals. Int J Mol Sci. 2019 Mar 06;20(5). PMCID: PMC6429069
 
Books, Chapters, and Reviews
1. Whelan HT: The Bends: Compressed Air in the History of Science, Diving and Engineering. Endeavor 23:186; 1999.
2. Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice, 2nd edition, Best Publishing, AZ, 1999.
3. Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice, 3rd edition, Best Publishing, AZ, 2008.
4. Whelan H, Desmet K, Buchmann E, Henry M, Wong-Riley M, Eells J, Verhoeve J. Harnessing the cell's own ability to repair and prevent neurodegenerative disease. SPIE Newsroom. 2008 Feb 24;2008:1-3. PMCID: PMC2644577
5. Whelan HT: Chapters in: Hyperbaric Medicine Practice, 3rd edition Best Publishing, AZ, 2008: a. Oxygen Toxicity, b. Neurologic Aspects of Hyperbaric Medicine, c. Effects of Hyperbaric Oxygen in Infectious Diseases: Basic Mechanisms, d. Gas Gangrene.
6. Helms A, Evans AW, Chu J, Sahgal A, Ostrowski R, Sosiak T, Wolf G, Gillett J, Whelan H. Hyperbaric oxygen for neurologic indications--action plan for multicenter trials in: stroke, traumatic brain injury, radiation encephalopathy & status migrainosus. Undersea Hyperb Med. 2011 Sep-Oct;38(5):309-19.
7. Kirton A, Armstrong-Wells J, Chang T, Deveber G, Rivkin MJ, Hernandez M, Carpenter J, Yager JY, Lynch JK, Ferriero DM, International Pediatric Stroke Study Investigators. Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics. 2011 Dec;128(6):e1402-10.
8. Helms A, and Whelan HT. Hyperbaric Oxygen for Stroke, Acute Ischemic Stroke InTech. 2012
9. Allen S, Kilian C, Phelps J, Whelan HT. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Support Care Cancer. 2012 Oct;20(10):2467-72.
10. Dowling MM, Hynan LS, Lo W, Licht DJ, McClure C, Yager JY, Dlamini N, Kirkham FJ, Deveber G, Pavlakis S, International Paediatric Stroke Study Group. International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke. 2013 Oct;8 Suppl A100:39-44. PMCID: PMC4940849
11. Whelan HT, Aaen GS, Sannagowdara K, DeMara-Hoth MB. Acute Cerebellar Ataxia. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Swaiman’s Pediatric Neurology: Principles and Practice. Elsevier, 2017. Pg. 701-705. Hardcover ISBN 9780323371018
12. Annis H, Keval A, Whelan HT. Oxygen Toxicity. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 49-66. ISBN 9781947239005
13. Willoughby Jr. RE, Falzon CC, Keval A, Whelan HT. Effects of Hyperbaric Oxygen in Infectious Diseases: Basic Mechanisms. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 379-405. ISBN 9781947239005
14. Keval A, Whelan HT. Gas Gangrene. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 407-432. ISBN 9781947239005
15. Whelan HT, Kilian C. The Use of Hyperbaric Oxygen for Treating Delayed Radiation Injuries in Gynecologic Malignancies. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 777-787. ISBN 9781947239005
16. Helms AK, Falzon CC, Keval A, Whelan HT. Neurologic Aspects of Hyperbaric Medicine. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 945-959. ISBN 9781947239005
17. Poff AM, Annis H, Whelan HT, Ari C, D’Agostino DP. Ketogenic Diet and Ketogenic Supplementation for Central Nervous System Oxygen Toxicity. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 995-1014. ISBN 9781947239005
18. Dituri J, Whelan HT. Submarine Rescue Diving and Hyperbaric Medicine. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 1015-1048. ISBN 9781947239005
19. Whelan HT, Leighton TL, Annis H, Dituri J. Ocean Exploration: Living in the Deep Sea. In: Whelan HT, Kindwall EP, editors. Hyperbaric Medicine Practice. 4th Edition. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 1133-1152. ISBN 9781947239005
20. Whelan HT: Kindwall EP, eds. Hyperbaric Medicine Practice, 4th edition, Best Publishing, FL, 2017.
21. Whelan HT, Aaen GS, Sannagowdara K, DeMara-Hoth MB. Acute Cerebellar Ataxia Swaiman’s Pediatric Neurology: Principles and Practice. Swaiman KF, Ashwal S, Ferriero DM, editors. Elsevier, 2017. Pg. 701-705.
22. Annis H, Keval A, Whelan HT. Oxygen Toxicity Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 49-66.
23. Willoughby Jr. RE, Falzon CC, Keval A, Whelan HT. Effects of Hyperbaric Oxygen in Infectious Diseases: Basic Mechanisms Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 379-405.
24. Keval A, Whelan HT. Gas Gangrene Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 407-432.
25. Whelan HT, Kilian C. The Use of Hyperbaric Oxygen for Treating Delayed Radiation Injuries in Gynecologic Malignancies Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 777-787.
26. Helms AK, Falzon CC, Keval A, Whelan HT. Neurologic Aspects of Hyperbaric Medicine Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 945-959.
27. Poff AM, Annis H, Whelan HT, Ari C, D’Agostino DP. Ketogenic Diet and Ketogenic Supplementation for Central Nervous System Oxygen Toxicity Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 995-1014.
28. Dituri J, Whelan HT. Submarine Rescue Diving and Hyperbaric Medicine Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 1015-1048.
29. Whelan HT, Leighton TL, Annis H, Dituri J. Ocean Exploration: Living in the Deep Sea Hyperbaric Medicine Practice, 4th edition.. Whelan HT, Kindwall EP, editors. North Palm Beach, FL: Best Publishing Company, 2017. Pgs. 1133-1152.
30. Kadamati P, Sugar JJ, Quirk BJ, Mehrvar S, Chelimsky GG, Whelan HT, Chelimsky TC, Ranji M. Near-infrared spectroscopy muscle oximetry of patients with postural orthostatic tachycardia syndrome. J Innov Opt Health Sci. 2018 Sep;11(6). PMCID: PMC6124683
31. Baldea I, Giurgiu L, Teacoe ID, Olteanu DE, Olteanu FC, Clichici S, Filip GA. Photodynamic Therapy in Melanoma - Where do we Stand? Curr Med Chem. 2018;25(40):5540-5563.
32. Antholine WE, Vasquez-Vivar J, Quirk BJ, Whelan HT, Wu PK, Park JI, Myers CR. Treatment of Cells and Tissues with Chromate Maximizes Mitochondrial 2Fe2S EPR Signals. Int J Mol Sci. 2019 Mar 06;20(5). PMCID: PMC6429069
 
Editorials, Letters to Editor, Other
1. United States Patent 7354432. Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury
2. US Patent Appl. No. 11/829,142. SYSTEM AND METHOD FOR CONVERGENT LIGHT THERAPY HAVING CONTROLLABLE DOSIMETRY
3. US Patent Appl. No. 11/197,061. METHOD AND APPARATUS FOR TREATING NEUROLOGICAL DISORDERS BY LIGHT STIMULATION
4. Perspective - LED light source modified to fight cancer; Fall, 1995.
5. Space Link - Light Emitting Diodes Technology; November 6, 1997.
6. American Society for Gravitational and Space Biology - Light emitting diodes for plant growth also activate tumor-treating drugs; November 6, 1997.
7. NASA News - Space research shines a light on tumors to save lives; November 6, 1997.
8. Aerotech News and Review - Space research shines a light on tumors to save lives; November 11, 1997.
9. The Space Report - Still saving lives; November 29, 1997.
10. Innovation Aerospace Technology - Space research shines life-saving light; November/December, 1997.
11. Optics.Org - LED's growing plants in space, may find important use in PDT; March, 1998.
12. CNN - Light being used to fight cancer; October 1, 1998.
13. Microgravity - Commercial LED's for cancer treatment illuminated by optical magazine; February, 1999.
14. OE Reports - New LED application promises effective cancer treatment; February 1999.
15. SpectraMedics - Light emitting diode therapy; September, 1999.
16. SPACEDAILY - Clotting Blood in Zero-G; September 23, 1999.
17. NASA Satellite Interviews - Major Breakthrough in Treating Children with Brain Cancer: NASA Spin-off Technology Makes it Happen; September 24, 1999.
18. Newscientist - Space healing, clotting blood in zero-g; September 25, 1999.
19. American Institute of Aeronautics and Astronautics - Brain Cancer Surgeries Successful Using Space-Age Probes; September 29, 1999.
20. NASA News - Brain Cancer surgeries successful using space-age probes; September 29, 1999.
21. SPACEDAILY - Space-Age Probe Helping Cancer Doctors; September 30, 1999.
22. Marshall Space Flight Center News Releases - First Brain Cancer Surgeries Using New Space-Age Probe are Successful; September 30, 1999.
23. NASA News - First Brain Cancer Surgeries Using New Space-Age Probe are Successful; September 30, 1999.
24. Space Illustrated - Space-age light probe makes the cut; October 4, 1999.
25. New Science - Attacking cancer with light; October 15, 1999.
26. New Science - Attacking Cancer with Light; October 18, 1999.
27. MSNBC - Space technology may speed healing; October 22, 1999.
28. Environmental Resources, Health & Medical Sciences - Cool light waves to treat brain tumors; October 29, 1999.
29. Oncology News - LED's Developed by NASA Used to Ablate Brain Tumors; January, 2000.
30. Current Science - Healing Rays; February 11, 2000.
31. NASA News - U.S. space foundation honors NASA Marshall program manager; April 27, 2000.
32. U.S. Space Foundation News Space Hall of Fame Inductees 2000 - Light emitting diodes for medical applications; April, 2000.
33. Journal of the National Naval Medical Center - Navy medicine takes on NASA for benefits; June 15, 2000.
34. The Balancing Act - Brain surgeries using space-age probes; October, 2000.
35. Biophotonics International - Can Light Hasten Healing in Space?; October, 2000.
36. Marshall Space Flight Center Success Stories - Space Research Shines a Light on Tumors to Save Lives; October, 2000.
37. NASA George C. Marshall Space Flight Center Brochure - LED's Lighting the Way for Cancer Treatment and Wound Healing; June, 2000.
38. NASA NEWS - NASA Space Technology; December, 2000.
39. Beyond 2000 - Medicine Treatments,(Light-Emitting Diode)Head Light; December 2000.
40. National Geographic - The Body In Space, Surviving the Odyssey; January 2001; Vol 199, pp 6-29.
41. Houston Chronicle - NASA shines a healing light on wounds - Space shuttle technology comes down to earth; February, 2001.
42. Popular Science - Light Makes Right; April, 2001.
43. National Geographic Channel - The Human Edge; December 08, 2001.
44. On Magazine - LED's do more than signal phone messages; October 2001
45. The Times of India - Infra-Red technique can cure lasers inflicted blindness; July 2002
46. NASA News - NASA Space Technology Shines Light on Healing. December 2000
47. BBC News - NASA laser could reverse blindness; July 2002
48. New Scientist - Light therapy tackles eye injuries. July 2002
49. Optics.org - LED's help treat blindness. July 2002
50. Florida today - Space technology helps advance cancer treatment. May 2002
51. Science News - NASA Laser May Cure Blindness. July 2002
52. Newsweek - Health: Shining a Light on Pain. March 2003
53. San Diego Tribune - LED therapy shows promise. June 2003
54. ARMY Times - New Light therapy tested on submarine's crew. June 2003
55. Wisconsin Technology Network - Medical College of Wisconsin researcher gets national defense appointment. October 2004
56. Richmond Times Dispatch - Doctors use light to treat cancer. April 28, 2005
57. LA Times- Researchers use Shining Light for Healing. May 22, 2005
58. Baltimore Sun - Lighting the way for new treatments. April 29, 2005
59. USA Weekend - Light That Can Cure You. February 4, 2007
60. Lake Effect, Milwaukee - Submarine Museum & Research interview. May 3rd, 2010
61. Lake Effect, Milwaukee - Diabetic Macular Edema Interview. June 2010
62. NBC Channel 5, Madison_- Cari's Hope. November 2010
 
Abstracts
1. Whelan HT, Huang YP, Putz GR, Taketa F: Hemoglobin genetics in the domestic cat. Federation Proceedings (FASEB) 1974;33:1451.
2. Whelan HT, Whelan M: Ego damage in medical school. The New Physician 1977;26:32-33.
3. Whelan HT, Letourneau PC, Tuszynski MH, Swaiman KF: Stimulation of neurite outgrowth by amphibian heart-conditioned medium. Society for Neuroscience Abstracts 1983;9:10.
4. Whelan HT, Lockman LA: Multiple idiopathic intra- and extra-cranial vascular occlusions without Moya-Moya. Child Neurology Society Abstracts 1983;12:217.
5. Whelan HT, Letourneau PC, Swaiman KF: Neurotrophic effects of adult amphibian explant-conditioned medium. Society for Neuroscience Abstracts 1984;10:370.
6. Whelan HT, Mastri AR: Primary diffuse meningeal gliomatosis in children. Annals of Neurology 1984;16:391.
7. Whelan HT: In vitro studies of fetal and adult CNS-regeneration. Annals of Neurology 1985;18:390.
8. Whelan HT, Clanton JA, Whetsell WO, Tolner DJ, Moore P, Kessler RW, Runge V: Magnetic resonance brain tumor imaging using an adult canine glioma model. Neurology 1986;36(Suppl):164.
9. Whelan HT: Neurological complications of uremia. Neurology Review 1986;1484:12.
10. Whelan HT, Moses H, Pledger J: The role of growth factors in the biology of a brain tumor cell line. Neurology 1987;37(Suppl):309.
11. Whelan HT, Clanton JA, Wilson RE, Tulipan NB: Comparison of x-ray CT and magnetic resonance brain tumor imaging using an adult canine glioma model. Annals of Neurology 1987;22:407-408.
12. Whelan HT: Management of childhood brain tumors. Neurology Review, 1987.
13. Whelan HT: Neurologic complications of cancer therapy. Neurology Review, 1987.
14. Whelan HT, Moses HL: Transforming growth factor beta in brain tumor biology. Society for Neuroscience Abstracts 1988;14:1162.
15. Partain CL, Powers TA, Kessler RM, Freeman MP, Robertson RH, Buchanan WJ, Freeland DS, Price RR, Pickens DR, Huber JC, and Whelan HT: Evaluation of gadolinium DTPA enhanced MRI in pediatric patients with masses in the brain and spinal cord. Society for Magnetic Resonance in Medicine, 7th Annual Meeting, San Francisco, 1988;1:5.
16. Whelan HT, Pledger J, Maciunas R, Galloway RL, Whetsell WO, Moses HL: The role of growth factors in the biology of a brain tumor cell line. Neurology 1989;39(Suppl 1):308.
17. Whelan HT, Strother DR, Li S: The use of MR-Imaging with MR-Spectroscopy in the study of medulloblastoma. Annals of Neurology 1989;26:455.
18. Whelan HT, Nelson DB, Strother DR, Przybylski C: Medulloblastoma cell line secretes platelet-derived growth actor. Neurology 1990;40(Suppl):131.
19. Whelan HT, Segura A, Donald Traul, Przybylski C, Sieber F: Interactions of merocyanine-540 with human brain tumor cells: preferential binding In Vivo and dye-sensitized photoinactivation In Vitro. Annals of Neurology 1991;30:459-60.
20. Whelan HT, Przybylski C, Kubacki DM, Schmidt MH: Intracellular growth factor metabolism in proliferation of a brain tumor cell line. Neurology 1992;42(3):421-422.
21. Whelan HT, Schmidt MH, Segura AD, Strother, D, Kubacki D, Meyer GA: The role of photodynamic therapy in posterior fossa brain tumors: a pre-clinical study in a canine glioma model. Annals of Neurology 1992;32(3):471.
22. Whelan HT, Ozker K, Bajic D, Schmidt MH, Liu Y, Trembath LA, Uzum F, Meyer GA, Segura AD, Collier BD: Selective uptake of 111In-Photofrin in posterior fossa brain tumors. Annals of Neurology 1993;34(3):469.
23. Whelan HT, Strother DR, Kovnar EH, Williams MB, Bajic DM, Flores R, Schmidt MH, Segura AD, McAuliffe TL, Chitambar CR: Gallium nitrate for microscopic disease in medulloblastoma:Preclinical study in a murine model. Pediatric NeuroSurg 1994;21:161
24. Whelan HT, Strother DR, Ozker K, Kras L, Schmidt MH, Liu Y, Trembath L, Uzum F, Meyer GA, Segura AD, Collier D, Kovnar EH: Selective incorporation of 111In-labeled Photofrin by glioma tissue in vivo. Pediatric NeuroSurg 1994;21:160-161.
25. Behnke CE, Reddy MN, Walsh DJ, Whelan HT: A simple and rapid method to determine felbamate. American Association for Clinical Chemistry Abstracts 1994.
26. Whelan HT, Bajic DM, Kindwall EP: Use of cytochrome P450 inhibitors to alter seizures caused by CNS oxygen toxicity. Undersea & Hyperbaric Medicine 1995;22(Supl):48.
27. Whelan HT: Neurologic Aspects of Undersea Medicine. AMSUS abstracts 1995;102:27.
28. Whelan HT, Bajic DM, Kindwall EP: Neuronal Culture Model of Central Nervous System Oxygen Toxicity. Neuroscience Abstracts 1995;21:1739.
29. Reichert KW, Schmidt MH, Meyer GA, Bajic DM, Whelan HT: Photodynamic therapy for childhood brain tumors. Child's Nervous System 1995;11:556.
30. Whelan HT, Bajic DM, Kindwall EP: The use of cytochrome P450 inhibitors to alter seizures caused by CNS-oxygen toxicity. Progress Report to: U.S. Navy Experimental Diving Unit 1996.
31. Karlovits SM, Bajic DM, Kindwall EP, Moulder JE, Whelan HT: Hyperbaric oxygen enhancement of radiation therapy via central nervous system oxygen toxicity suppression. Society for Neuroscience Abstracts 1997;23:2205.
32. Whelan HT, Kindwall EP: Hyperbaric oxygen: Some unanswered questions despite clinical usefulness. Proceedings, International Society on Oxygen Transport to Tissue 1997.
33. Whelan HT, Houle JM, Bajic DM, Schmidt MH, Reichert KW, Meyer GA: Benzoporphyrin derivative and light-emitting diode for use in photodynamic therapy: applications of space light-emitting diode technology. Proceedings, Institute for Space and Nuclear Power Studies 1998.
34. Whelan HT, Houle JM, Bajic DM, Schmidt MH, Reichert KW, Weyenberg GT, Meyer GA: Medical applications of space light-emitting diode technology: Space station and beyond. Special Operations Medical Conference 1998.
35. Whelan HT: Medical Aspects of Special Warfare Automated Mission Planning System. Special Operations Medical Conference 1999.
36. Whelan HT: NASA-LED Medical Program Proceedings of Institute for Space & Nuclear Power Studies 2000.
37. Zupec-Kania BA, Werner RR, Pick BA, Wilfong AA, Jacobson RD, Kovnar EH, Walsh DJ, Whelan HT: Rapid Initiation of the Ketogenic Diet without the Traditional Fasting Period. Annals of Neurology 2000.
38. Whelan HT: NASA-LED Medical Applications - Deep Space to Deep Sea. Proceedings of Institute for Space & Nuclear Power Studies 2001.
39. Ellie C, Lanzafame RJ, Oskoui P, Stadler I, Whelan HT: Altered Osmotic Fragility of Red Cells After Near-infrared NASA LED Photoradiation is not ATP Dependent. ASLMS Annual Meeting 2001.
40. Stadler I, Lanzafame RJ, Whelan HT: NASA LED Photoradiation Influences Nitric Oxide and Collagen Production in Wounded Rats. ASLMS Annual Meeting 2001.
41. Wong-Riley MTT, Bai X, Buchmann E, Whelan HT: Near Infrared Light Reverses the Down-Regulation of Cytochrome Oxidase by TXX in Rat Visual Cortical Neurons in Culture. Society for Neuroscience Abstr., #619.10,2001.
42. Eells JT, Henry MM, Summerfelt P, Buchmann EV, Whelan HT: Protection Against Methanol-Induced Retinal Toxicity by LED Photostimulation. Society of Toxicology Annual Meeting 2001.
43. Whelan HT, Wong-Riley MTT, Eells JT: Effects of Near Infrared Light on Methanol-Induced Mitochondrial Dysfunction in the Retina. The International Society for Optical Engineering 2002.
44. Whelan HT, Wong-Riley MT, Eells JT: Effects of near-infrared light on methanol-induced mitochondrial dysfunction in the retina. Proceedings of Photonics West 2002: Biomedical Optics Symposium (BiOS), 2002
45. Wong-Riley MTT, Liang HL, Eells J, Whelan HT: Effects of Potassium Cyanide and Light-emitting Diode Treatment on Cytochrome Oxidase Activity in Primary Neuronal Cultures.3rd International Nearfield Optical Analysis Meeting, Futura 2002, Brazil.
46. Wong-Riley M, Liang HL, Eells J, Whelan HT: Effects of various wavelengths in the near infrared range on cytochrome c oxidase in primary neurons functionally inactivated by tetrodotoxin. The 12th European Bioenergetics Conference (EBEC), Arcachon, France, 2002.
47. Scheidt M, Wong-Riley MTT, Eells J, Whelan HT: Near infrared led light treatment of normal and monocularly-deprived rat visual cortex up-regulates cytochrome oxidase activity in vivo. Soc. Neurosci. Abstr., #131.21, 2002.
48. Wong-Riley MTT, Whelan HT, Dhokalia A, Das R, Hammamieh R, Liang HL, Eells J, Jett M: cDNA microarray analysis of the visual cortex exposed to light-emitting diode treatment in monocularly enucleated rats. Soc. Neurosci. Abstr., #131.20, 2002.
49. Wong-Riley MTT, Whelan HT, Hammamieh R, Dhokalia A, Das R, Liang HL, Eells J, Jett M: cDNA microarray analysis of changes in gene expression during postnatal development of the rat visual cortex. Soc. Neurosci. Abstr., #266.18, 2003.
50. Liang HL, Eells J, Whelan HT, Wong-Riley M: Effects of different sequences of wavelengths with light-emitting diodes on cytochrome oxidase in primary visual cortical neurons functionally inactivated by TTX. Soc. Neurosci. Abstr., #701.17, 2003.
51. Ver Hoeve JN, Nork TM, Kim CBY, Hennes B, Kaufman P, Whelan HT, Eells J: Supernormal multifocal ERG after macular grid photocoagulation. Association for Research in Vision and Ophthalmology (ARVO). Investigative Ophthalmology & Visual Science. Abstract 45;4239, 2004
52. Eells JT, Whelan HT, Salomao S, Berezovsky A, Moraes M, Paula H, Sherman J, Lam T, Sadun AA: 670 nm LED Treatment of Affected Carriers of the 11778 Leber's Hereditary Optic Neuropathy (LHON) Mutation in Brazil. Association for Research in Vision and Ophthalmology (ARVO). Investigative Ophthalmology & Visual Science. Abstract 45;828,2004.
53. Whelan HT, Wong-Riley MTT, Eells JT, VerHoeve JN, Das R, Jett M: DARPA Soldier Self Care : Rapid Healing of Laser Eye Injuries with Light Emitting Diode Technology (LED)
54. North Atlantic Treaty Organization (NATO) Symposium Combat Casualty Care in Ground Based Tactical Situations: Trauma Technology Emergency Medical Procedures, MP-HFM-109P19 August, 2004.
55. Eells JT, Whelan HT, Wong-Riley MTT, Henry MM, Summerfelt P, VerHoeve J, Lam T, Sadun AA, Moraes M, Berezovsky A, Salomao S.: The mitochondrial link between oxidative stress and visual dysfunction. Int. Cong Eye Res (ICER), Sydney, Australia, 2004.
56. Liang HL, Whelan HT, Buchmann EV, Kane MP, Wong-Riley M: Near-infrared light/light emitting diode treatment protects against apoptosis induced by KCN. Soc. Neurosci. Abstract #795;11, 2004.
57. Whelan HT, Wong-Riley MTT, Eells JT, VerHoeve JN: Photobiomodulation for Acute Traumatic Neurological Injury with Light-Emitting Diode (LED) Lasers in the Modern Battlefield XXVIth Annual Conference February 2005.
58. DeSmet KD, Henry MM, Buchmann E, Connelly M, Whelan HT, Eells JT: Near-Infrared Light Treatment in a Cellular Model of Mitochondrial Dysfunction. The Toxicologist CD -- An official Journal of the Society of Toxicology, Volume 89, Number S-1, March 2005.
59. Eells JT, Whelan HT, Salomao S, Berezovsky A, Paula H, Moraes M, Sherman J, Lam T, Sadun AA: 670 nm LED Treatment of Affected Carriers of the 11778 Leber's Hereditary Optic Neuropathy (LHON) Mutation in Brazil Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL. 2005.
60. Eells JT, DeSmet KD, Henry MM, VerHoeve J, Wong-Riley MTT, Das R, Jett M, Whelan HT: Near-Infrared Light Therapy for Retinal Injury and Disease. Ocular Cell Molecular Biology Conference, Sarasota Florida, 2005
61. Eells JT, DeSmet KD, Henry MM, Wong-Riley MT, Whelan HT, VerHoeve J, Das R, Jett M: Effect of Near-infrared Light Therapy on Methanol Intoxication-Induced Alterations in Retinal Gene Expression. The Toxicologist CD -- An official Journal of the Society of Toxicology, Volume 90, Number S-1, March 2006
62. DeSmet K, Henry MM, Buchmann E, Wong-Riley M, Whelan HT, Eells JT: Near-Infrared Light Therapy for Parkinson's Disease. The Toxicologist CD -- An official Journal of the Society of Toxicology, Volume 90, Number S-1, March 2006.
63. Yeager RL, Lim J, Millsap DS, Sanders RA, Watkins JB, Whelan HT, Eells JT, Henshel DS: Near Infrared Light Therapy Attenuates Dioxin-Induced Embryo Mortality. The Toxicologist CD -- An official Journal of the Society of Toxicology. Volume 90, Number S-1, March 2006.
64. VerHoeve JN, Kim CBY, Nork TM, Hennes E, Eells J, Whelan HT: 670 nm Photostimulation Improves Retinal Electrical Response Following Laser Lesions. The Association for Research in Vision and Ophthalmology Annual meeting. May 2006.
65. Eells JT, DeSmet KD, Kirk DK, Cribb J, Valter K, VerHoeve JN, Whelan HT, Stone J: Near Infrared Light Therapy for Retinitis Pigmentosa. Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL. 2006.
66. Whelan HT, Eells J, Wong-Riley M, Das R, Jett M, VerHoeve J: Photomodulation of Cytochrome Oxidase Annals of Neurology. 2006;60. (S10):S143 (49).
67. Whelan HT: Photomodulation of Cytochrome Oxidase. Neuropediatrics. 2006;37. (S1):MP83. Accessed online at http://www.thieme-connect.com/ejournals/toc/neuropediatrics DOI: 10.1055/s-2006-943680.
68. Helms AK, Torbey MT, Whelan HT: Hyperbaric Oxygen for Acute Ischemic Stroke: Need for a Better Study. Undersea and Hyperbaric Medicine 34:275, 2007.
69. Dituri J, Knafelc ME, Whelan HT: ISOBARIC COUNTERDIFFUSION DIVING FOR THE U.S. Navy. UHMS 2007
70. Dituri J, Whelan HT: Lightweight, Faster Decompression and Portable Alternative to U.S. Navy Mixed Gas Diving. Undersea and Hyperbaric Medicine 34:255, 2007.
71. Whelan HT, Muir D: Photodynamic Therapy for Dermal NF1 Tumors [CNS abstract 10]. Ann Neurol. 2007;62(suppl):S98
72. Telega DH, Desmet KD, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Jeitner TM, Whelan HT: Near-infrared Light Emitting Diode (NIR-LED) Treatment and Prevention of Neurodegenerative Disease Demonstrated Using Cellular and Animal Models of Parkinson Disease (PD) [CNS abstract P17]. Ann Neurol. 2007:62(suppl):S109
73. Dituri J, Parsley K, Hamilton RW, Whelan HT: Could the U.S. Navy Benefit from Technical Diving Techniques? UHMS 2008
74. Desmet KD, Buchmann EV, Henry MM, Wong-Riley MT, Eells JT, Verhoeve J, Whelan HT: Harnessing the Cell's Own Ability to Repair and Prevent Neurodegenerative Disease. CNS 2008
75. Desmet KD, Buchmann EV, Henry MM, Wong-Riley MT, Eells JT, Verhoeve J, Whelan HT: Harnessing the Cell's Own Ability to Repair and Prevent Neurodegenerative Disease. SPIE 2009
76. Desmet KD, Buchmann EV, Henry MM, Wong-Riley MT, Eells JT, Verhoeve J, Whelan HT: Near Infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury. ASLMS 2009
77. Photobiomodulation of Mitochondrial Mechanisms in Neurodegenerative Disease. Harry T. Whelan, MD, Michele M. Henry, BS, Ellen V. Buchmann, BS, Margaret Wong-Riley, PhD, Janis T. Eells, PhD and Kristina DeSmet, MS. Annals of Neurology 66(Suppl. 13):S108; 2009.
78. Near-infrared light treatment in an in vitro model of traumatic brain injury, Michele M. Henry, BS, Colleen Maroney, BS, Ellen V. Buchmann, BS, Harry T. Whelan, MD Society for Neuroscience Abstracts 2009.
79. Near-infrared Photobiomodulation is Neuroprotective in a Transgenic Mouse Model of Parkinson's Disease. Harry T. Whelan, MD, Michele M. Henry, BS, Ellen V. Buchmann, BS, Margaret Wong-Riley, PhD, Janis T. Eells, PhD and Kristina DeSmet, MS. Society for Neuroscience Abstracts 2009.
80. Phototherapy's Effect on the ATP Levels of Vinblastine-Poisoned HERS Cells. K. Jones, Kyle Menne, Brian D. Hodgson, Ellen Buchmann, Brendan Quirk, and Harry T. Whelan. 2011
81. Long-Wavelength, Low-Intensity Photon Therapy (LLPT) for Traumatic Brain Injury. Harry T. Whelan, Michel Torbey, Sumit Verma, Brendan Quirk, Brandy Jones, Joeylynn Nawrocki, Ellen Buchmann. Neurology (Suppl. 4)76:A162; 2011
82. Near Infrared Pulsating Converging Beam Device for Photodynamic Therapy of Brain Tumors. E. Rietema, Harry T. Whelan, MD. Light Sources 2012
83. The use of Hyperbaric Oxygen for Treating Delayed Radiation Injuries in Gynecologic Malignancies: A Review of Literature and Report of Radiation Injury Incidence. 86. Scott Allen, M.D, Chris Kilian, M.D, Jenise Phelps, M.D., Harry T. Whelan, M.D. UHMS 2012
84. Hemodynamic response associated with interictal and ictal epileptiform discharcharges using simultaneous video electroencephalography (vEEG)/Near Infrared Spectoroscopy (NIRS). Harry T. Whelan, M.D., Xiuhua Bozarth, M.D., Priya Monrad, M.D., Kurt Hecox, M.D., Jenna Prigge, PNP. AAN 2013
85. Harry T. Whelan, M.D., Xiuhua Bozarth, M.D., Priya Monrad, M.D., Kurt Hecox, M.D., Jenna Prigge, PNP. Hemodynamic response associated with interictal and ictal epileptiform discharcharges using simultaneous video electroencephalography (vEEG)/Near Infrared Spectoroscopy (NIRS). Neurology 2013;80(Meeting Abstracts AAN 2013)
86. O’Connor, S., Dituri, J., Vigilante, J., DiGeorge, N., Bear, A., Kenyon,J., Whelan, H.T. Ketogenic Diet to decrease central nervous system oxygen toxicity symptoms in divers. UHMS 2013
87. Jogal, S., Kaufmann, B., Foy, A., Lew, S., Quirk, B., Whelan, H.T., Photodymamic Therapy of Brain Tumors. Society for Neuro-oncology 2013.
88. Parachuri, V., Katyayan, A., Whelan, H.T. Photodynamic therapy (PDT) for brain tumors. Neurology April 8, 2014 vol. 82 no. 10 Supplement P7.019.
89. Whelan HT, Renaldo C, Guined J, Dituri J. Project Poseidon: Medical Requirements for Establishing a SeaSpace Station. UHMS Mar-Apr 2017 Vol 44, No. 2
90. Chelimsky,G., Quirk,B., Welzig,C., Chelimsky,T., Prieto,T., Mueller,A., Figueroa,J., Wallner,D., Whelan, H. Near-Infrared Spectroscopy in Pediatric Orthostatic Disorders, AAS Proceedings 2014.
91. Heather Annis, M.D., J. Dituri MS, T. Boschuetz MS4, D. Kirsten MS4, M. Hansen MS4, H. Whelan MD, Recruiting Divers to Study the Ketogenic Diet and Central Nervous System Oxygen Toxicity Symptoms, Undersea & Hyperbaric Medical Society (UHMS) 2015 Annual Scientific Meeting, Montreal, Canada 2015
92. K. Sannagowdara, M. Ranji, H.T. Whelan: Basic Principle of Near Infrared Spectroscopy: Application in monitoring cerebral oxygenation and neural energy metabolism. Society for Neuroscience Annual Meeting, Chicago, Illinois, 2015
93. Kumar Sannagowdara, Priya Monrad, Kurt Hecox, Michael Schwabe, Michael Meyer, Jenna Prigge, Harry Whelan: Hemodynamic Changes Associating with Interictal Epileptiform Activities using Simultaneous video Electro-encephalography (EEG)/Near Infrared Spectroscopy (NIRS) in patient Self Control Study, American Clinical Neurophysiology Society (ACNS) 2016 meeting, Orlando FL, Feb 2016
94. Dituri J, Sadler R, Sidiqi F, Sadler C, Javeed N, Annis H, Whelan H Echocardiographic evaluation of intracardiac venous gas emboli following in-water recompression, Undersea & Hyperbaric Medical Society Inc., UHMS Mar-Apr 2016 Vol 43, No.2
95. Harry Whelan, In Water Recompression for Undersea Diving, Undersea & Hyperbaric Medical Society Annual Scientific Meeting, Las Vegas, NV, 06/11/2016
96. Harry Whelan, Ketogenic Diet for Prevention of Central Nervous System Oxygen Toxicity in Closed-Circuit Oxygen Rebreather Diving, Conference on Nutritional Ketosis and Metabolic Therapeutics: Epigenix Foundation, Tampa, FL, 02/04/2017
97. Harry Whelan, Ketosis as a Neuroprotective Mechanism to CNS Toxicity in Divers Exposed to High Partial Pressure of Oxygen (PO2), Undersea & Hyperbaric Medical Society Annual Scientific Meeting, Orlando, FL, 06/28/2018
98. Harry Whelan, Neurobiological and Physiological Measurements From Free Swimming Marine Mammals, Undersea & Hyperbaric Medical Society Annual Scientific Meeting, San Juan, Puerto Rico, 06/28/2019
 

jenkins-FCD Prod-411 e00897e83867fcfa48419861683711f8d99adb75